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Abstract 
Land application of chicken litter from production houses that use the 
organoarsenical 3-nitro-4-hydroxybenzenearsonic acid (roxarsone) results in deposition 
of significant quantities of arsenic into United States soil each year.  Used widely as a 
feed additive in the poultry industry, roxarsone was originally thought to be stable in the 
environment.  However, recent evidence from our lab, as well as others, has established 
that this benign compound is readily transformed via several intermediates into inorganic 
arsenate.  While microbial activity has been implicated in this process, there is no direct 
evidence suggesting the specific processes or the organisms involved.   
Using a physiological and proteomic approach, this study demonstrates increased 
anaerobic growth of the arsenate respiring Clostridium species strain OhILAs in the 
presence of roxarsone using two different carbon sources, as well as provides evidence to 
suggest the respiratory arsenate reductase (Arr) system may be constitutively expressed.  
Increased growth of Clostridium OhILAs was coupled to a loss of roxarsone as 
determined by spectrophotometric assays.  Similar results have been obtained with the 
structurally similar ortho-nitrophenol.  Additionally, arsenate reductase activity assays of 
OhILAs grown in the presence of lactate alone or in the presence of lactate and either 
roxarsone, ortho-nitrophenol or sodium arsenate have suggested that the respiratory 
arsenate reductase is constitutively expressed.  
 
 
1 
Introduction 
 
 In 1996, Bryan Sykes and colleagues published a controversial paper in the July 
issue of the American Journal of Human Genetics challenging the long-held belief that 
most of modern man's genetic influence came from an agricultural “wave of advance” 
postulated by Luigi Luca Cavalli-Sforza in the 1970's.  While ultimately the challenge 
was upheld, and genetics has continued to reveal most of our genetic ancestry is rooted in 
our Paleolithic hunter-gatherer ancestor's genetics, there is no question that the 
agricultural revolution has had, and continues to be, a great source of environmental 
change (Sykes, 2001).  In time, forests have been felled, landscapes have been altered and 
animals have become domesticated for the direct benefit of man.  Unseen for most of this 
process have been the indirect affects associated with agriculture. 
 Unlike our distant agricultural relatives with small-scale subsistence level 
operations, recent agriculture has seen the development of vast corporate farms and 
concentrated animal feeding operations (CAFOs).  Recently, surface waters have been 
inundated by impacts from eroding fields, fecal contamination and the spread of 
agricultural chemicals such as hormones, antibiotics and pesticides.  Unchecked use of 
agricultural compounds, as well as a lack of knowledge of how these compounds behave 
when released into the environment, has led to a situation where potentially dangerous 
compounds, such as the organoarsenical roxarsone, see common use throughout the 
industry.  Despite mankind's technological advances and attempted withdrawal from the 
environment, we are still intimately connected to our environment.  Ultimately, adverse 
impacts to our environment lead to adversely impacting human health. 
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 One such compound that has come under recent investigation is 3-nitro-4-
hydroxybenzene arsonic acid (roxarsone).  Used widely as a poultry feed additive to 
prevent coccidiosis infections, roxarsone has been marketed under the trade names 3-
Nitro, 3-Nitro-10, 3-Nitro-20, and roxarsone for use both as a coccidiostat and as a 
growth promoter (Abdo, 1989). 
 Under the premise that this compound is stable when released into the 
environment, chicken litter containing the compound is readily applied to fields as 
fertilizer; though recent evidence suggests that this compound may not be entirely stable 
when released (Cortinas et al., 2006) (Stolz et al., 2007).  The mechanisms by which 
roxarsone transforms in the structurally similar compound 3-amino-4-hydroxybenzene 
arsonic acid (3-A-4-HBAA) and ultimately into inorganic arsenate [As(V)]] are, as of yet, 
largely unknown.  However, there is mounting evidence that demonstrates this process 
does occur, and at very rapid rates (Christen, 2006).  
 This present study examines the microbial physiology and proteomics of 
Clostridium species strain OhILAs  (Figure 1).  This organism was originally isolated by 
Asia Dawson from the Stolz Lab (Duquesne University) based on its ability to reduce 
arsenate to arsenite during anaerobic respiration (Fisher et al., 2007).  Interestingly, pure 
cultures of OhILAs grown in the presence of roxarsone are capable of transforming the 
compound to 3-A-4-HBAA and inorganic arsenate (Stolz et al., 2007).  Using a 
physiological and proteomic approach, this study suggests that the nitrate group on the 
aromatic ring serves as the terminal electron acceptor during anaerobic respiration by 
OhILAs (Stolz et al., 2007). 
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Figure 1:  Transmission electron micrograph of Clostridium sp. strain OhILAs.  Courtesy of Jonathan 
Franks. 
4 
Environmental Cycling of Arsenic 
 In 1776 a group of rebellious individuals in the American Colonies sent word that 
they would sever ties with their mother country, England.  Sitting on the throne of 
England, and receiving this treasonous declaration, was King George III.  One of 
England's longest reigning monarchs, King George was monarch for some of England's 
finest moments.  Among these, the development of the feared British Navy, defeat of 
Napoleonic France and massive expansion of the British Empire.  Nonetheless, he is best 
remembered for two exigencies:  his loss of the American Colonies and his five bouts of 
madness.  While the loss of the colonies has been the subject of much debate, and 
countless theses in history, for the present purpose it is more interesting to note historians 
widely agree the most likely explanation for his madness was a genetic metabolic 
disturbance known as porphyria.  What is not understood is why these attacks were so 
severe, and lasted for very long durations (Cox et al., 2005). 
 Heavy metals such as lead and mercury are known to perturb haem biosynthetic 
pathways and can serve as initiating factors for porphyria attacks.  In 2005, researchers 
from several universities including the University of Kent published a study in which the 
metals content of King George's hair was analyzed.  Though mercury levels were normal, 
and the level of lead was only slightly higher than would be expected, the levels of 
arsenic contained in the hair far exceeded the expected range.  The arsenic content of 
King George's hair is consistent with arsenic poisoning (Cox et al., 2005), however the 
current hypothesis for the abundance of arsenic, as well as the precipitation of the king's 
porphyric attacks is far more interesting, and of much more importance to the 
understanding of how arsenic cycles in the environment. 
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 Arsenic is the twentieth most abundant element in the earth's crust (Francesconi &  
Kuehnelt, 2002), with a natural abundance of 1.8 parts per million and increasing 
concentrations in areas of high volcanic activity (Goessler &  Kuehnelt, 2002).  
Throughout history, arsenic has been associated with the extremes of industry, medicine 
and murder.  Co-occuring with minerals of copper, Bronze Age smiths using primitive 
smelting operations would have, by chance, created copper-arsenic alloys.  While the 
scientific knowledge of why a particular mineral gave a better alloy, the smiths would 
have been able to select for minerals that would have yielded alloys with the desirable 
arsenic to copper ratio.  In ancient Egypt as well as China, arsenic was used to produce 
silver surfaces on mirrors and statues.  Arsenic has seen use in the leather industry, 
painting, and arsenic sulfide (As2S3) as well as realgar ( As2S2 ) were used by alchemists 
in hopes of extracting gold (Nriagu, 2002). 
 Arsenic has also been of historical importance as a medicinal agent.  Initially used 
to treat external diseases of horse and sheep, arsenic eventually moved into a prominent 
role as a medicinal agent (Nriagu, 2002).  Indeed, according to Nriagu (2002), when the 
nineteenth century closed every major disease known was subject to arsenotherapy; from 
external treatment of skin diseases to ingestion of Fowler's solution to treat anemia and 
leukemia. 
 However, arsenic's most well know association is with that of murder.  From a 
prominent role in John Kesselring's play Arsenic and Old Lace to its fame as “inheritance 
powder,” the mere mention of arsenic carries with it images of murder and suicide.  Until 
1836, when James Marsh published a method for detecting low levels of arsenic (Taylor, 
1875) arsenic remained the poison of choice for the upper class.  While exact figures are 
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unknown, J Beckman (1846) estimates that 600 people were murdered by Aqua della 
Toffana, a generic name for poisons in Europe during the century between 1630 and 1730 
(Nriagu, 2002). 
 Naturally occurring arsenic occurs in four oxidation states:  As (-III), As(0), 
As(III) and As(V) (Oremland & Stolz, 2003), the most abundant of which is arsenate 
[As(V)] (Francesconi &  Kuehnelt, 2002).  Even though As(V) is the most commonly 
found form of natural arsenic, arsenite [As(III)] is found in relatively high abundance in 
anoxic sediments where microbiological processes reduce As(V) to As(III) (Oremland & 
Stolz, 2003).  This shift demonstrates the microbiological cycling of the element from the 
pentavalent form to the trivalent form. 
 Arsenic in any form is toxic to most organisms, though some organisms possess 
resistance mechanisms to the toxin.  Commonly, this system functions through some 
form of methylation followed by selective transport out of the cell (Newman, 2006) 
(Ratnaike, 2003).  Interestingly, there are some organisms that can couple reduction of 
arsenate to arsenite with production of adenosine triphosphate (ATP), thus generating 
energy for the cell.  At present, there are 24 microorganisms able to use arsenic as the 
terminal electron acceptor for production of ATP (Stolz et al., 2006).  These organisms 
use arsenate much like oxygen is used by aerobic organisms; as the terminal electron 
acceptor in the aerobic electron transport chain (Oremland & Stolz, 2003).  It is possible 
that these organisms mobilize mineralized arsenic into water supplies; a great concern in 
areas of West Bengal and Bangladesh, India.  Within the United States, there is also 
concern of groundwater contamination. 
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Chakraborti and colleagues (2002) report that currently nine districts in West 
Bengal are impacted by arsenic contamination of their water sources.  In 19 blocks of the 
region known as Murshidabad, 3.2 million people are served by an estimated 130,000 
tube wells.  Chakraborti and colleagues surveyed 22,274 of these wells, and found that a 
stagger sixty-six percent contained greater than ten parts per million.  Of these wells, 
thirty-two percent had a concentration greater than fifty parts per million arsenic.  The 
human health considerations of this are staggering (Chakraborti et al., 2002). 
 The researchers estimate that more than six million individuals are consuming 
water severely contaminated with arsenic, and that more than 300,000 individuals suffer 
from arsenical skin lesions.  Of the 8,500 people clinically examined, 3,100 had 
identifiable skin lesions.  In a single block in Murshidabad, 45 patients were likely 
suffering from Bowen's carcinoma, 13 suffering from non-healing ulcer and eight had 
already lost limbs to cancer or gangrene.  In a single family of eighteen, all nine adults 
examined had sever arsenical skin lesions and were suspected to have Bowen's carcinoma 
(Chakraborti et al., 2002). 
 Arsenic contamination of groundwater in Bangladesh tells a similar story.  Of 663 
water samples analyzed, close to eighty percent had arsenic concentrations in excess of 
fifty parts per million.  Again, extensive clinical examination of those affected revealed a 
high portion of the population suffering from arsenical skin lesions, ulcers and various 
forms of cancer (Chakraborti et al., 2002). 
 As discussed, the problems of high level arsenic exposure, exposure in excess of 
fifty parts per million, have been well documented in areas such as Bangladesh and West 
Bengal, India, arsenic at any levels are of concern.  Recently, the Environmental 
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Protection Agency has enacted changes regarding permissible levels of arsenic in 
drinking water.  These recent changes have suggested a non-enforceable target level of 0 
parts per billion, with an enforceable level of ten parts per billion.  It is important to note 
that these changes stem from rising health concerns regarding chronic exposure to low to 
moderate levels of arsenic, levels between ten and fifty parts per billion (EPA, 2001).  
These levels are of one magnitude less than those documented by Chakraborti. 
 In New England, concentrations of arsenic within this level are known to occur 
within groundwater.  A study conducted to characterize regional occurrence of arsenic in 
aquifers in parts of New England found that of the 88 aquifers studied, 34% had arsenic 
concentrations in excess of 10 ppb, with the highest percentage exceeding this 
concentration being found in bedrock wells composed mainly of metamorphosed marine 
sediments (Ayotte et al., 2003).  Arsenic levels in this range are implicated in a wide 
range of skin, bladder and lung cancers (Ratnaike, 2003). 
 What, then, is the connection of the arsenic redox cycle with a monarch that 
passed away over 300 years ago?  The answer is in the mineralization of arsenic.  Though 
arsenic is a relatively abundant element, it most frequently occurs in mineral form.  
Without the aid of microbial processes, mineralized arsenic is generally found in close 
association with several ores such as gold, copper, lead (Oremland & Stolz, 2003) or 
antimony (Cox et al., 2005).  A close examination of King George III's medical records 
reveal he often took antimony to help with stomach pains (Cox et al., 2005). 
 Interestingly, previous estimates have indicated that the level of arsenic 
contamination in antimonial drugs may have reached as high as five percent during the 
period in which the king lived.  Cox et al (2005) estimate this could lead to ingestion of 
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nearly nine milligrams of arsenic per day, and would thus lead to chronic high level 
arsenic exposure.  While there has been no direct link between arsenic and onset of 
porphyric attacks, arsenic is known to react with sulphydryl groups in the haem 
biosynthesis pathway (Apostoli et al., 2002) (Woods & Southern, 1989).  The current 
hypothesis is that the antimony he took was unable to be purified away from the closely 
associated arsenic based on chemical purification methods in place at that time.  The 
metalloid arsenic then acted in much the same way as heavy-metals do and exacerbated 
his porphyrria (Cox et al., 2005). 
 
Human Health Concerns 
 Arsenic is an element of great renown for its historical role as a poison.  The 
potent poison arsenic trioxide has been referred to as “The Poison of Kings” and received 
acclaim as inheritance powder during the middle ages for its role in eliminating spouses, 
lovers and the heads of the great households (Nriagu, 2002).  The minimum lethal 
amount is between sixty and eighty milligrams in a single dose (Ratnaike, 2003).  
However, because of its extended residence time, chronic exposure to lower levels, levels 
below fifty micrograms still leads to sever consequences.  As previously mentioned, this 
is of very real concern both abroad in places such as West Bengal, India, but is also of 
much concern closer, in areas such as the New England region of the United States. 
 While the problems of high level arsenic exposure arsenic at any levels are of 
concern.  As previously discussed, the recent EPA changes have suggested a non-
enforceable target level of zero parts per billion arsenic in drinking water, with an 
enforceable level of ten parts per billion stemming from health concerns regarding 
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chronic low and moderate exposure (EPA, 2001).  In many areas of the United States, 
drinking wells do not meet this criteria (Figure 2). 
 To understand the human health impact of arsenic, it is important to understand 
how the two prevalent arsenic oxidation states, arsenate [As(V)] and arsenite [As (III)], 
act at the cellular level.  Initially absorbed in the small intestine by a protein gradient 
requiring electrogenic process, arsenic is generally biomethylated in the liver to 
monomethylarsonic acid (MMA) or dimethylarsonic (DMA) acid.  These two 
compounds, while not completely harmless, are substantially less toxic than either 
arsenate or arsenite.  However, it takes between three and five days for half of the arsenic 
ingested to be excreted in the urine.  Because of this resonance time, low level exposure 
to arsenic can lead to chronically elevated levels in tissue (Ratnaike, 2003).   
 Chemically, arsenate is analogous to phosphorous.  Consequently, arsenate is able 
to be substituted for phosphorous in compounds central to cellular metabolism (Ratnaike, 
2003).  Indeed, arsenate's toxicity is based in its ability to uncouple oxidative 
phosphorylation associated with the enzyme glyceradehyde 3-phosphate dehydrogenase 
subsequently disrupting a key step in glycolysis.  Many bacteria have a detoxifying 
arsenate reductase mechanism, the arsC system, which reduces internal pools of arsenate 
to arsenite.  Arsenite is then removed by an active ion pump (Oremland et al., 2002).  
Though arsenate's toxicity is based in its ability to mimic phosphorous and uncouple a 
key step of the glycolytic pathway, the more oxidized form of arsenic, arsenite, binds 
thiol groups within proteins (Oremland & Stolz, 2003).  Consequently, many bacteria 
have developed novel modes of detoxification.  Because arsenate is less toxic than  
11 
 
 
Figure 2:  Arsenic concentrations in the United States. (Chou et al., 2005). 
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arsenite, some organisms are able to oxidize arsenite to arsenate, using oxygen as the 
terminal electron acceptor.  Of more importance, especially in organisms that reduce 
arsenate to arsenite as a detoxification mechanism, is the function of ArsB. 
The most thoroughly studied ars operon is that of plasmid R773 which consists of 
five genes: arsR, arsD, arsA, arsB and arsC.  While not all operons in living systems 
contain all five genes, representative sequences suggest that, at a minimum ArsC, must be 
expressed for arsenate resistance.  Ars C is a small cytoplasmic arsenate reductase that 
catalizes the reaction from As(V) to As(III).  Indeed, it is the only protein of the ars 
operon to catalyze such a reaction.  By reducing As(V) to As(III), the As (III) is then 
selectively exported out of the cell by either ArsB alone, or with the heteromultimer 
ArsAB pump (Silver et al., 2002).   
ArsB is a membrane protein involved in arsenite and antimonite resistance.  By 
pumping these metalloid oxyanions from the cells (Silver et al., 2002) the cell is able to 
lessen the internal pool of arsenite in the cytosol.  ArsB alone selectively passes arsenite 
out of the cell, deriving energy solely from the cell's membrane potential.  Interestingly, 
in the presence of a functioning arsA gene, an ArsAB complex forms.  Deriving energy 
from hydrolysis of adenosine tri-phosphate (ATP), this transport protein is able to 
actively pump arsenite out of the cell without relying on a pre-established gradient for the 
energy requirement (Silver et al., 2002). 
Less studied in this system are the roles of ArsR and ArsD.  The evidence would 
suggest that these proteins may act in regulation of the operon.  Indeed, Silver reports that 
As(III) binding to ArsR induces a conformational change.  This conformational shift 
results in release of the repressor protein, ArsD, from the operator DNA.  As yet, no 
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evolutionary importance has been assigned to ArsD as its absence has little effect 
underlaboratory conditions.  However, the high frequency of this protein suggests a 
subtle role in selection that is not yet understood (Silver et al., 2002). 
 A survey of the literature reveals the importance that this theme of detoxification 
and removal plays an important role in bacterial resistance mechanisms to both arsenite 
and arsenate.  Additionally, it is interesting to note that eukaryotes possess several 
resistance mechanisms which are not homologous to the mechanisms seen in prokaryotes, 
but have evolved independently.  In Saccharomyces cerevisiae, this theme continues 
whereby Arr2 (previously Acr2p) reduces arsenate to arsenite, and the ARR3 (previously 
ACR3) gene product catalyzes arsenite extrustion from the cell (Silver et al., 2002). 
 Given that arsenic is a known carcinogen it is readily understood why there is 
such diversity and importance put on the role of detoxification and removal at the cellular 
level.  It is interesting, though, to realize that neither arsenate nor arsenite directly 
damage deoxyribonucleic acid (DNA).  However, exposure to arsenic leads to the 
inactivation of up to two hundred enzymes.  Of these, the most noted are thos that are 
involved in deoxyribonucleic acid replication and repair (Ratnaike, 2003).  Recent 
evidence has also suggested that arsenic may play a role in altering the function of 
enzymes.  One such example is altered function of the glucocorticoid receptor (GR) in 
response to arsenite exposure. 
 To examine the effect of arsenic on the glucocorticoid receptor, Kaltreider and 
colleagues created luciferase constructs that were under control of a glucocorticoid 
response element.  Using the synthetic glucocortoid dexamethasone, the researchers were 
able to monitor the effect of dexamethasone on cells exposed to dexamethasone alone, or 
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pre-treated with non-cytotoxic doses of arsenite, levels below 3.3 µM.  The researchers 
demonstrated that pre-treatment with varying concentrations of an arsenite pre-treatment 
yielded correspondingly lower expression of the GRE:luciferase construct despite 
subsequent studies demonstrating that glucocorticoid concentration and translocation 
remained unaffected.  These results suggest that arsenite may interfere with the receptors 
ability to initiate nuclear transcription, though the mechanism behind this remains 
unresolved (Kaltreider et al., 2001). 
 In large part, the actual mechanisms behind arsenic toxicity remain unknown.  As 
previously discussed, arsenic does not directly damage DNA, but does inactivate 
enzymes as well as alter the function of other enzymes.  Nonetheless, acute and chronic 
arsenic exposure results in various clinical manifestations.  Generally, acute poisoning of 
less than five milligrams results in vomiting and diarrhea.  However, these symptoms 
resolve in less than twelve hours, and no treatment is necessary.  At the lethal level of 
acute poisoning, levels greater than one hundred milligrams, patients invariably present 
with problems of the gastrointestinal system including vomiting and diarrhea.  
Ultimately, death results from severe dehydration at these levels of exposure (Ratnaike, 
2003). 
 Of greater importance is the clinical manifestation of those exposed to chronic 
low-level arsenic.  In patients suffering from chronic low-level arsenic poisoning, affects 
to most major systems of the body are reported.  Initially, as with acute poisoning, 
patients typically present with gastrointestinal problems including diarrhea and vomiting.  
Left untreated, however, arsenic leads to changes in the cardiovascular system, 
neurological system, genitourinary system, respiratory system and the endocrine systems.  
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Compounding this, in regions where chronic low-level exposure is prevalent, fetuses, 
infants and children are exposed to increasingly higher levels of arsenic from their 
mother.  In the Andes, another locale in which chronic exposure is prevalent, mothers 
drinking water containing arsenic concentrations of approximately two hundred parts per 
billion had elevated levels of placental arsenic.  Additionally, the toxin is passed to 
infants and children through breast milk further exposing the children to low levels of 
arsenic (Ratnaike, 2003). 
 
Industrial Uses of Arsenic 
 Historically, arsenicals have seen use as pesticides starting in the mid nineteenth 
century and continuing until the advent of organic pesticides cause the use of them to 
wan in the 1940's.  Among these, calcium arsenate, lead arsenate, sodium arsenite and 
sodium arsenate were the dominant compounds used.  Owing largely to an increased 
awareness of human health and environmental risks associated with continued use of 
these compounds, use has largely disappeared since 1960 (Chou et al., 2005).  In 1993, 
amid growing concern, food uses and use on cotton plants were voluntarily halted (Chou 
et al., 2005). 
 However, despite arsenic's toxicity it continues to see a wide variety of industrial 
applications.  The United States alone used 21,600 metric tons in 2003.  By far the 
leading use, laying claim to over 90% of arsenic application in 2003, was for production 
of chromated copper arsenate (CCA), a wood preservative.  The remaining 10% resulted 
in the production of agricultural products such as fertilizers, herbicides and insecticides.  
According to the 2005 draft toxicity report, CCA is widely used as a wood preservative 
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throughout the world.  In 1997, 20.6 million cubic meters of wood were treated with 
CCA, and marketed as pressure treated  (Chou et al., 2005).  Though CCA manufacturers 
began a volunteer transition from CCA to other preservatives in 2003, there has been a 
lag in such actions impacting other industries.  Among these uses is the use of the 
organoarsenical centrally important to this study, roxarsone, as an antimicrobial feed 
additive in the poultry industry. 
 While roxarsone was initially approved for use in the mid-1960s as an 
antimicrobial, it has recently come under much investigation.  Anderson and Chamblee 
(2001) conducted a study involving arsenic deposition patterns in chicks fed roxarsone 
versus those not fed roxarsone.  Of the possible deposition patters, the pattern observed 
was consistent with what the researchers expected for organisms with no tissue 
absorption of the metalloid.  As the chicks grew and had higher food consumption, more 
arsenic was deposited in their feces.  However, after being given the withdrawal food, 
food that contained no roxarsone, total arsenic concentration started to drop.  However, it 
is interesting to note that the samples taken prior to slaughter contained approximately 6 
parts per million (ppm) of arsenic, while samples taken from the control groups had an 
experimental high of 0.53 ppm (Anderson &  Chamblee, 2001). 
 
Current Research 
 As previously mentioned, roxarsone is an organoarsenical that has seen 
widespread use in the poultry industry; initially for the prevention of coccidiosis 
infections, but later to stimulate increased broiler growth and plumage coloration 
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(Salsbury Laboratories, 1981).  The dosage of roxarsone ranges from 22.7 to 45.4 g of 
roxarsone per ton of chicken feed (Alpharma, 1999).  According to Garbarino et al (2003)  
estimates, this equates to approximately 9 x 105 kg of Roxarsone, or 2.5 x 105 kg of 
arsenic on the soils of the United States from the manure (Garbarino et al., 2003).  
Hardest hit with this arsenic deposition are those states which lead the nation in poultry 
production (Figure 3). 
 In 1969, Morrison concluded that use of roxarsone did not increase the arsenic 
levels in soil or crops.  Fields having poultry litter (15 to 30 mg/kg arsenic) applied at a 
rate of 4 to 6 tons per year for twenty years were compared to fields having no history of 
poultry litter treatment.  While the soil, alfalfa crop and clover crop showed no significant 
differences in arsenic concentrations between the fields, drainage from the treated fields 
contained 0.29 mg/L of arsenic (Morrison, 1969).  Similarly, in a study of roxarsone 
transport in agricultural watersheds, Brown et al (2005) found that there was not a 
significant difference in total arsenic concentration in soils treated with poultry litter 
compared to those not treated with poultry litter (Brown et al., 2005).  However, another 
study suggested that there is an increase in soil arsenic levels in fields treated with 
poultry litter (Gupta & Charles, 1999). 
 Recent evidence from our laboratory, and others, has suggested that microbial 
transformation of the organoarsenical can occur under anaerobic conditions (Figure 4).  
Garbarino et al (2003) demonstrated that soils treated with poultry litter transformed 90% 
of roxarsone present in composting experiments into As(V) in 23 days.  Complete 
transformation occurred by day 38 (Garbarino et al., 2003).  Studies have also identified 
several intermediates either existing in the degradation pathway, or as an alternate 
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Figure 3:  Map of United States Poultry Production.  
http://www.nass.usda.gov/Charts_and_Maps/Poultry/brlmap.asp 
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Figure 4:  Anaerobic transformation of roxarsone. Chicken litter enrichments (A) and cultures of 
Clostridium sp. OhILAs (B)  (Stolz et al 2007).  Error bars represent standard error of the mean (SEM) as 
calculated from triplicate cultures.   
 
Reproduced in part with permission from Stolz, J. F., Perera, E., Kilonzo, B., Kail, B., Crable, B., Fisher, 
E., Ranganathan, M., Wormer, L. & Basu, P.  Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid 
(roxarsone) and release of inorganic arsenic by Clostridium species. Environ Sci Technol, 41, 818-23.  
Copyright 2007  American Chemical Society. 
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terminal transformation product (Rosal et al., 2005) (Stolz et al., 2007).  Some of these 
compounds, such as 3-A-4-HBAA, are readily soluble in water (Rutherford et al., 2003) 
further contributing to increased arsenic levels in waterways and raising health concerns, 
both human and environmental, around the United States.  
Cortinas and colleagues (2006) found that enrichment cultures obtained from 
sewage sludge were capable of transforming roxarsone.  Cultures grown under 
methanogenic, methanogenic plus lactate, or sulfate reducing conditions demonstrated 
almost complete transformation of roxarsone as determined by high performance liquid 
chromatography (HPLC) in less than twenty-five days.  Abiotic, heat-killed and cultures 
grown under denitrifying conditions showed little to no transformation.   
HPLC of the resulting media demonstrated that on day ten, the cultures had 
produced between 0.5 and 0.6 mM of 3A4HBAA  from the initial concentration of 
roxarsone (1 mM), with continued production of 3A4HBAA to the final data point on day 
sixteen.  Ultimately, the molar yield of 3A4HBAA was equal to 86% of the roxarsone 
removed from the cultures.  Subsequently, the researchers investigated the long-term 
stability of the transformation compounds and found extensive transformation of 
3A4HBAA in extended incubation cultures to levels below 0.2 mM (Cortinas et al., 
2006). Unfortunately, the microbial composition of the enrichments was not identified.  
While the chicken cecum has a vastly diverse microbial community, it has been well 
established that Clostridia are the dominant species of the chicken cecum.  Here, we have 
examined the microbial transformation of roxarsone using a pure strain of Clostridium, 
Clostridium sp. strain OhILAs . 
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 Preliminary data from our laboratory suggests that in anaerobic cultures 
inoculated with OhILAs, as well as cultures inoculated from a chicken litter enrichment 
slurry (received from M. Schreiber at Virginia Polytechnic Institute and State University) 
transform roxarsone at pH 7.3.  Chicken litter cultures have shown rapid transformation 
of 1 mM roxarsone into 3-A-4-HBAA and As(V) (Figure 4A).  Interestingly, As(V) 
began at 84 hours was preceeded by production of 3-A-4-HBAA appearing at 72 hours.  
By 192 hours, phenol was detected (Figure 4A).  A similar pattern was noticed for the 
cultures inoculated with OhILAs (Figure 4B).  Additionally, As(III) was detected after 48 
hours (Figure 4B).  No abiotic transformation was detected in heat-killed cultures. 
 While great progress has been made in this field of arsenic respiring microbes, 
there is still quite a bit of work that needs to be done.  Currently, several microbes have 
been identified that will transform arsenate [As(V)] into the more toxic arsenite [As(III)]. 
Similarly, it has been identified that certain strains of Clostridium sp., as well as 
microorganisms in chicken litter, have the ability to transform roxarsone into a variety of 
end products, including 3-A-4-HBAA (3-A-4-HBAA).  However, the specific mechanism 
behind this has yet to be determined, though a likely mechanism has been proposed.  In 
this model, the nitro group on the aromatic ring is first reduced to an amine to form 3-A-
4-HBAA (Figure 5).  Though evidence from previous studies suggests this is an 
acceptable first step, the remainder of the pathway, that of deamination of the aromatic 
ring and subsequent release of the arsenic group, is entirely speculative.  While this will 
take many more years of research to reach an acceptable model, the current study 
provides critical framework from which to build such a model.  
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Figure 5:  Proposed mechanism of roxarsone transformation.  Reduction of the nitro group is followed 
by deamination of 3-A-4-HBAA.  Subsequent release of the arsenic group may occur. 
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Master’s Thesis Specific Aims 
 
1. Determine if  other carbon substrates (e.g., glycerol, fructose, pyruvate, butyrate) 
can serve as electron donors to the reduction of roxarsone.  
 
2. Determine whether growth supplements (e.g., selenium) are necessary for 
Clostridium sp. OhILAs to transform 3-amino-4-hydroxyphenylarsonic acid or 4-
hydroxyphenylarsonic acid. 
 
3. Determine whether the respiratory arsenate reductase and resistance arsenate 
reductase appear in the proteome of Clostridium sp. OhILAs when grown in the 
presence of organoarsenicals (e.g., roxarsone, 3-amino-4-hydroxyphenylarsonic 
acid, 4-hydroxyphenylarsonic acid) 
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Materials and Methods 
 
Cell Culture Experiments: 
 For all cell culture experiments, the organisms were grown at ambient 
temperatures on either a minimal media (OhBs) containing or a complex (OhSt) media.  
In one liter, OhBs contained 0.095 g magnesium chloride (Fisher Scientific, Hanover 
Park, IL; FW 203.31), 4.2 g sodium bicarbonate (Fisher Scientific; FW – 84.01), 1 g 
yeast extract (Sigma-Aldrich, St. Louis, MO) and 10 ml of a 100X mineral mix (appendix 
1) and 2 ml of a 500X vitamin mix (appendix 1).  OhSt contained in one liter 0.225 g 
potassium phosphate monobasic (Sigma Aldrich; FW 136.1), 0.225 g potassium 
phosphate dibasic (Sigma Aldrich; FW 136.1), 1 g sodium chloride (Fisher Scientific 
catalog; FW 58.44), 0.178 g ammonium chloride (Fisher Scientific; FW 53.49), 0.095 g 
magnesium chloride, 3 g yeast extract, 4.2 g sodium bicarbonate, 0.2 g sodium sulfide 
(Sigma Aldrich) and 1 ml of a 1 mM sodium selenite (Sigma Aldrich; FW 172.94), 10 ml 
of a 100X mineral mix (appendix 1) and 2 ml of a 500X vitamin mix (appendix 1).  The 
pH of the prepared media was adjusted to 7.5 and 100 ml aliquots were degassed with 
high purity nitrogen (Airgas, Radnor, PA) passed through heated copper coils to remove 
any contaminating oxygen.  Media was degassed for ten minutes in 125 ml crimp-top 
sealable bottles.  After the bottles were sealed, the media was then heat sterilized at 
121oC and 20 psi for forty-five minutes.  After cooling to ambient temperatures, 
necessary amendments were made using stock solutions prepared in either OhSt or OhBs 
transferred using a Beckton-Dickinson 3 ml syringe and a FisherBrand 0.22um syringe 
filter (pre-sterilized).  All cell culture experiments were conducted in triplicate with a 
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sterile (uninoculated) sample as control.  Cultures were swirled by hand prior to sampling 
to ensure equal distribution of the organisms.  Figure 6 illustrates the experimental design 
for the cell culture experiments. 
 
Chicken Litter Enrichment ~ roxarsone 
 Here, the ability of microbial enrichments obtained from chicken litter to 
transform roxarsone was investigated using lactate as the initial carbon source.  Chicken 
litter from the Shenandoah Valley of Virginia, was obtained from Madeline Schreiber, 
Associate Professor of Hydrogeosciences, Virginia Polytechnic Institute and State 
University, Blacksburg, Virginia.  A 100 ml bottle of OhBs media was temporarily 
unsealed, and five grams of chicken litter was added to form a chicken litter slurry.  The 
bottle was immediately resealed, and allowed to incubate at ambient temperature for 
thirty minutes to one hour before being used to inoculate experimental cultures.  This 
time allowed aerobic organisms in the culture to deplete any introduced oxygen and re-
established an anoxic atmosphere. 
 100 ml aliquots of OhBs media were amended as previously described with 1 ml 
of a 1M stock solution of sodium lactate (Sigma Aldrich), prepared in OhBs, to a final 
concentration of 10 mM.  roxarsone (Acros Organics, Morris Plains, NJ; FW 263.03) 
containing cultures were also amended as previously described with 2 ml of a 50 mM 
stock solution of roxarsone, to a final concentration of 1 mM.  After amendment, 
experimental cultures were inoculated with 1 ml of the chicken litter slurry transferred 
aseptically via a 3 ml Beckton-Dickinson syringe. 
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Figure 6:  Cell culture experimental design.  Triplicate experimental cultures were incubated at ambient 
temperatures.  3 ml of sample collected at specified time points for duration of experiment.  1 ml reserved 
for turbidimetry, 1 ml filter sterilized using a 0.22 µm syring filter and 1 ml was filter sterilized and 
acidified with 200 µl of 2 N sulfuric acid. 
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 Samples were collected initially and at specified timepoints throughout the 
duration of the experiment by withdrawing 3 ml of the experimental and abiotic control 
cultures using a syringe.  A 1 ml aliquot of the sample was immediately transferred to a 
FisherBrand microcentrifuge tube and stored at -20oC until spectrophotometric analysis.  
Another 1 ml aliquote was filter sterilized using a FisherBrand 0.22 µm syringe filter and 
stored at -20oC until spectrophotometric analysis.  An additional 1 ml aliquot was needed 
for high performance liquid chromatography analysis.  This aliquot was filter sterilized 
and acidified using 200 µl of a 2N sulfuric acid (H2SO4) (Fisher Scientific) solution.  
These samples were stored in glass vials at -20oC. 
 
Clostridium sp. strain OhILAs pure culture experiments ~ roxarsone  
Here, the ability of  pure strain Clostridium sp. strain OhILAs to transform 
roxarsone was investigated using lactate or fructose (Fisher Scientific; FW 180.16) as the 
initial carbon source and electron donor where indicated.  Stock cultures were maintained 
on OhSt prepared under an atmosphere of nitrogen.  Prior to transfer, purity of strain was 
determined using phase contrast microscopy.  Slides were prepared using 1 drop of the 
stock culture and observed at a total magnification of 400X. 
 100 ml aliquots of OhBs media were amended as previously described with 1 ml 
of a 1M stock solution of sodium lactate or fructose as indicated, prepared in OhBs, to a 
final concentration of 10 mM.  roxarsone containing cultures were also amended as 
previously described with 2 ml of a 50 mM stock solution of roxarsone, to a final 
concentration of 1 mM.  After amendment, experimental cultures were inoculated with 1 
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ml of the stock culture at log phase was transferred aseptically via a 3 ml Beckton-
Dickinson syringe. 
 Samples were collected initially and at specified timepoints throughout the 
duration of the experiment by withdrawing 3 ml of the experimental and abiotic control 
cultures using a syringe.  A 1 ml aliquot of the sample was immediately transferred to a 
FisherBrand microcentrifuge tube and stored at -20oC until spectrophotometric analysis.  
Another 1 ml aliquot was filter sterilized using a FisherBrand 0.22 µm syringe filter and 
stored at -20oC until spectrophotometric analysis.  An additional 1 ml aliquot was needed 
for high performance liquid chromatography analysis.  This aliquot was filter sterilized 
and acidified using 200 µl of a 2N sulfuric acid (H2SO4) solution.  These samples were 
stored in glass vials at -20oC. 
 
Cell Turbidity Measurements 
 Turbidity was monitored at 600 nm using a Perkin Elmer Lambda 2S dual band 
spectrophotometer and standard 1.5 ml quartz cuvettes with a 1 cm pathlength.  The 
spectrophotometer was zeroed using 1 ml of sterile OhBs as reference.  Unfiltered 
samples from pure culture experiments were thawed and stored on ice except during 
analysis.  Absorbance of the samples at 600 nm was recorded.  The data was graphed 
using GraphPad Prism 5.0 using the “Three Replicates” method to calculate standard 
error. 
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Microbial transformation of 2-nitrophenol 
2-nitrophenol (Acros Organics catalog; FW 139.11) is a nitroaromatic that is 
similar in structure to roxarsone with the notable exception that this compound lacks an 
arsenic group.  Here, the ability of microbial enrichments obtained from chicken litter 
and pure strain Clostridium sp. strain OhILAs to transform additional organoarsenicals 
present in the proposed degradation pathway was investigated using lactate or fructose as 
the initial carbon source as indicated.  Chicken litter slurry and stock cultures of OhILAs 
were prepared as previously described. 
100 ml aliquots of OhBs media were amended as previously described with 1 ml 
of a 1M stock solution of sodium lactate or fructose as indicated, prepared in OhBs, to a 
final concentration of 10 mM.  2-nitrophenol containing cultures were also amended as 
previously described with 2 ml of a 50 mM stock solution of 2-nitrophenol, to a final 
concentration of 1 mM.  After amendment, experimental cultures were inoculated with 1 
ml of the chicken litter slurry or stock culture of log phase Clostridium sp. strain OhILAs 
was transferred aseptically via a 3 ml Beckton-Dickinson syringe.  Samples were 
collected as previously described. 
 
Microbial transformation of 3-A-4-HBAA and 4-hydroxybenzene arsonic acid 
Here, the ability of microbial enrichments obtained from chicken litter and pure 
strain Clostridium sp. strain OhILAs to transform additional organoarsenicals present in 
the proposed degradation pathway was investigated using lactate or fructose as the initial 
carbon source as indicated.  Chicken litter slurry and stock cultures of OhILAs were 
prepared as previously described. 
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90 ml aliquots of OhBs media were amended as previously described with 1 ml of 
a 1M stock solution of sodium lactate or fructose as indicated, prepared in OhBs, to a 
final concentration of 10 mM.  3-A-4-HBAA (City Chemical, LLC) containing cultures 
were also amended with 10 ml of a 10 mM stock solution of 3-A-4-HBAA to a final 
concentration of 1 mM. 
100 ml aliquots of OhBs media were amended as previously described with 1 ml 
of a 1M stock solution of sodium lactate or fructose as indicated, prepared in OhBs, to a 
final concentration of 10 mM.  4-hydroxybenzene arsonic acid (City Chemical, LLC) 
containing cultures were also amended with 1 ml of a 100 mM stock solution of 3-A-4-
HBAA to a final concentration of 1 mM. 
 After inoculation with 1 ml of chicken litter slurry or 1 ml of log phase OhILAs 
stock culture, samples were collected as previously described. 
 
Aerobic Chicken Litter Enrichment ~ roxarsone 
 Here, the ability of microbial enrichments obtained from chicken litter to 
transform roxarsone under aerobic conditions was investigated using lactate as the initial 
carbon source.  Aerobic OhBs media was prepared as previously described without 
degassing.  Aerobic chicken litter slurry was prepared as previously described, without 
degassing. 
 100 ml aliquots of OhBs media were amended as previously described with 1 ml 
of a 1M stock solution of sodium lactate, prepared in OhBs, to a final concentration of 10 
mM.  roxarsone containing cultures were also amended as previously described with 2 ml 
of a 50 mM stock solution of roxarsone, to a final concentration of 1 mM.  After 
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amendment, experimental cultures were inoculated with 1 ml of the chicken litter slurry 
transferred aseptically via a 3 ml Beckton-Dickinson syringe. 
 Samples were collected initially and at specified timepoints throughout the 
duration of the experiment by withdrawing 3 ml of the experimental and abiotic control 
cultures using a syringe.  A 1 ml aliquot of the sample was immediately transferred to a 
FisherBrand microcentrifuge tube and stored at -20oC until spectrophotometric analysis.  
Another 1 ml aliquote was filter sterilized using a FisherBrand 0.22 µm syringe filter and 
stored at -20oC until spectrophotometric analysis.  An additional 1 ml aliquot was needed 
for high performance liquid chromatography analysis.  This aliquot was filter sterilized 
and acidified using 200 µl of a 2N sulfuric acid (H2SO4) solution.  These samples were 
stored in glass vials at -20oC. 
 
Colorimetric assay for determination of roxarsone concentration 
 Full wavelength scans of roxarsone using a Perkin Elmer Lambda 2S dual band 
spectrophotometer and standard quartz cuvettes with a 1 cm pathlength have shown that 
it has a peak absorbance at approximately 400 nm (Fisher, 2006).  A standard curve of 
absorbance at 400 nm versus concentration was constructed using the following 
concentrations of roxarsone:  0.5 M, 0.25 M, 0.15 M, 0.1 M, 0.050 M and 0.025 M.  The 
standard curve was constructed in GraphPad Prism using the “Single Values” method.  A 
linear regression was run and and an extinction coefficient was calculated as the slope of 
the linear regression.  Filtered samples from pure culture experiments were diluted one in 
ten and absorbance at 400 nm was recorded.  Concentration of roxarsone was calculated 
using Beer’s Law of 
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where A is equal to the absorbance, l is equal to the pathlength of the cuvette (1 cm) and 
ε is equal to the previously determined extinction coefficient of the compound.  To 
compensate for the dilution factor, this value was multiplied by ten. 
 
Colorimetric assay for determination of 2-nitrophenol concentration 
 Full wavelength spectrophotometric scans of 2-nitrophenol have shown that it has 
a peak absorbance at approximately 417 nm.  A standard curve of absorbance at 410 nm 
versus concentration was constructed using the following concentrations of 2-
nitrophenol:  500 µM, 250 µM, 150 µM, 100 µM and 50 µM.  The standard curve was 
constructed in GraphPad Prism using the “Single Values” method.  A linear regression 
was run and and an extinction coefficient was calculated as the slope of the linear 
regression.  Concentration of 2-nitrophenol was calculated using Beer’s Law of 
 
where A is equal to the absorbance, l is equal to the pathlength of the cuvette (1 cm) and 
ε is equal to the previously determined extinction coefficient of the compound. 
 
Investigations into the proteome of Clostridium sp. strain OhILAs 
 To investigate changes in the proteom of OhILAs grown under 10 mM lactate, 10 
mM lactate and roxarsone, 10 mM lactate and 2-nitrophenol or 10 mM lactate and 5 mM 
sodium arsenate conditions, 1.8 L cultures of a complex lactate containing media 
(OhProt) comprised of OhSt media with the addition of 2.8 ml per liter 60% sodium 
lactate (Sigma Aldrich) prior to autoclaving was prepared.  The media was placed in a 1.8 
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L crimp-top sealable anaerobic culture bottle and degassed with nitrogen for ten minutes 
using a diffuser.  After degassing, the bottles were sealed and the media was heat 
sterilized at 121oC and 20 psi for sixty-five minutes.  The media was then amended with 
stock solutions prepared as described earlier to final concentrations of 10 mM lactate 
alone or 10 mM lactate and 1 mM of either roxarsone, 2-nitrophenol or sodium arsenate. 
 Cultures were incubated at ambient temperature for 72 hours.  The cultures were 
then decanted into 1L centrifuge bottles and centrifuged at 7200 revolutions per minute 
(rpm) for thirty minutes at 4oC.  The supernatant was decanted and the cell pellet was re-
suspended in approximately 15 ml of a buffer (lysis buffer #1) containing 20 mM Tris-
HCl (Fisher Scientific; FW 121.14), 100 mM potassium chloride (J. T. Baker, 
Phillipsburg, NJ; FW 74.56), 0.1 mM ethylenediamine tetraacetic acid (EDTA) (Fisher 
Scientific; FW 372.24) and 1 mM dithiothreitol (DTT) (ACROS; FW 154.24).   
After like cultures had been combined into 50 ml conical tubes, the cells were 
washed three times.  To wash the cells, the cell suspension was centrifuged again at 7200 
rpm for ten minutes at 4oC.  The buffer was decanted and replaced with fresh lysis buffer 
#1.  After the final wash, the cell pellet was stored at -80oC. 
 
Cell lysis and fractionation 
 To separate the soluble and insoluble fractions, a combination of French Pressure 
Cell Lysis technique (French press) and ultracentrifugation was used.  The pellets were 
allowed to thaw at 4oC and resuspended in 3 ml of lysis buffer #1.  The components of 
the mini-cell apparatus for French press were incubated in ice for 20 minutes prior to 
French pressing the cell suspension.  For each sample, the cell suspension was placed into 
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the assembled mini-cell apparatus.  Cells were lysed at an internal pressure of 15,000 psi 
(750 psi external) through two consecutive passes. 
 The lysed cell suspension was then placed into an ultracentrifuge tube.  Tubes 
were balanced to within 0.005 g using additional lysis buffer #1 where necessary.  Protein 
suspensions were spun at 40,000 rpm (150,00 x gravity) in a Beckman Class S 
ultracentrifuge using rotor 50.2Ti for 2 hours.  The supernatant containing the soluble 
fraction of proteins was decanted and immediately stored at -80oC for further 
experiments.  The insoluble pellet was resupended in 1 ml of lysis buffer #1 and 
immediated stored at -80oC for further experiments. 
 
Quantification of proteins 
 In all cases, concentration of protein in both soluble and insoluble fractions were 
quantified using the BioRad Quick Start Protein Assay Kit.  As per the kit’s instructions, 
a standard of curve of 20 µl of 2, 1.5, 1, 0.75, 0.5, 0.25, 0.125 µg/µl concentrations was 
prepared using 20 µl of nanopure water as a blank.  The necessary volume of included 
prepared dye was allowed to warm to ambient temperature.  1 ml of this dye was added to 
the 20 µl of either sterile water or protein standard and allowed to incubate at room 
temperature for at least 15 minutes but no longer than one hour.  Standard quartz cuvettes 
of 1cm pathlength were used and the spec was zeroed using the 20 µl nanopure water as 
the reference cuvette.   All standards were prepared in duplicate.  A standard curve of the 
absorbance at 595 nm versus protein concentration was prepared using GraphPad Prism 
5.0.  The extinction coefficient (0.5935 L mole-1 cm-1) was calculated as the slope of the 
linear regression. 
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 Five microliters of unknown concentration of protein suspension was diluted to 
20 µl with lysis buffer #1.  A reference of 20 µl of lysis buffer #1 was prepared.  To each 
of the unknown protein samples, and reference, 1 ml of the BioRad Quick Start Protein 
Assay Dye warmed to ambient temperatures was added.  Samples were allowed to 
incubate at ambient temperature for at least 15 minutes but no longer than 1 hour.  Using 
the 20 µl lysis buffer #1 sample as reference, the absorbance at 595 nm of the samples of 
unknown concentration was recorded.  The unknown concentration was calculated using 
Beer’s Law.   
 
This concentration was then multiplied by four to account for the one in four dilution 
compared to the standard curve. 
 
Precipitation of proteins by trichloroacetic acid 
 To remove lipids and concentrate protein samples, samples were subjected to 
precipitation by trichloroacetic acid where noted.  A volume of sample equal to 500 µg of 
protein was brought to a 1 ml volume with lysis buffer #1.  To this, 50 µl of a 100% 
trichloroacetic acid (TCA) was added and samples were incubated on ice for the amount 
of time noted in subsequent experiments.  The samples were spun at 7200 rpm at 4oC for 
ten minutes and the supernatant was decanted.  The pellet was washed with 100% 
acetone chilled to -20oC and centrifuged again at 7200 rpm at 4oC for ten additional 
minutes.  The acetone was then decanted and the pellet was allowed to air dry at ambient 
temperature for approximately five minutes.  The pellet was then resuspended in the 
experiment specific buffer as noted in subsequent experiments.  Several samples were 
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prepared simultaneously.  Protein yield and concentration were determined as previously 
described using protein suspended in a buffer (lysis buffer 2d) containing 7M urea 
(Fisher Scientific; FW 60.06), 2M thiourea (Fisher Scientific; FW 76.12), 4% (w/v) 3-
[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesul-fonate (CHAPS) (AppliChem, 
Cheshire, CT; FW 614.89) and 10 mM DTT.  
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis of proteins 
 To separate proteins in a polyacrylamide matrix, two primary methods of gel 
electrophoresis were employed, sodium dodecyl sulfate polyacrylamide gel 
electrophoreses (SDS-PAGE) and two-dimensional (2D) PAGE.  For SDS-PAGE 7 cm 
gels, pre-cast gels were purchased from BioRad Laboratories (Hercules, CA).  Precast 
7.5% acrylamide ten well gels were purchased from BioRad laboratories as were 12% 
gels with ten wells and fifteen wells.  All precast gels came with a 4% acrylamide 
stacking gel. 
 Protein fractions that did not undergo TCA precipitation were used for all native 
gels where indicated, while TCA precipitated suspensions were used for all denaturing 
gels where indicated.  A volume of suspension equal to 70 µg (for Coommassie staining) 
or 5 µg (silver staining) was diluted in the appropriate buffer.  For native SDS-PAGE, a 
buffer (native buffer) containing in one ml 250 µl of a 0.5 M Tris-HCl (pH 6.8) buffer, 
300 µl of a 20% sodium dodecyl sulfate (SDS) (Sigma Aldrich; FW 288.38), 200 µl of 
100% glycerol (Sigma Aldrich) and 250 µl of nano pure water.  For denaturing SDS-
PAGE, a buffer (denaturing buffer) containing in one ml 250 µl of a 0.5 M Tris-HCl (pH 
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6.8) buffer, 300 µl 20% SDS, 200 µl 100% glycerol, 100 µl 2-mercaptoethanol (Sigma 
Aldrich catalog) and 150 µl nano pure water. 
 For staining of gels with coomassie brilliant blue (described later), a volume of 
protein suspension equal to 35 µg protein was diluted to a volume of 20 µl with the 
appropriate buffer as noted throughout.  For staining of gels using the silver salts 
(described later), a volume of protein suspension equal to 5 µg protein was diluted to a 
volume of 20 µl with the appropriate buffer as noted throughout.  Where noted, denatured 
samples were heated for ten minutes at 90oC in a Thermolyne type 17600 sandbath.  20 µl 
of the protein suspension was loaded into separate wells.  Into remaining wells, 5 µl of 
BioRad AllBlue pre-stained protein standards were loaded or BioRad Laemmli sample 
buffer to serve as a visible dye front for tracking progress of the gel. 
 Gels were run using the BioRad ProteanII system (BioRad discontinued item) and 
a Tris-Glycine-SDS buffer (running buffer) containing, in one liter, 22.5 g Glycine 
(Fisher Scientific; FW 75.06), 4.5 g Tris and 1.0 g SDS.  Gels were run at a constant 
voltage as noted throughout until the dye front reached the bottom of the gel.  Gels were 
then removed from the apparatus for further use. 
 Larger format gels (16 cm) were poured by hand using the formulations found in 
Table 1. 
 
Two dimensional gel electrophoresis 
 While SDS-PAGE is useful for separating proteins based on molecular weight, a 
more powerful technique, known as two dimensional gel electrophoresis (2D PAGE) is 
able to separate proteins in a first dimension based on isoelectric point (pI).  Subsequent 
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 Table 1:  Formulations for large format SDS-PAGE Gels.  All compounds except TEMED were mixed together 
and degassed by vaccuum for 10 minutes.  Gels were immediately cast upon addition of TEMED.  Resolving gel 
was overlayed with an equal parts mixture of butanol to 0.5M Tris-HCl (pH 6.8) buffer.  40% Acrylamide purchased 
from BioRad (catalog # 161-0144).  TEMED (catalog # BP150-100) and ammonium persulfate (catalog # A-1433) 
purchased from Fisher Scientific. 
 4% Stacking Gel 7.5% Resolving Gel 10% Resolving Gel 12% Resolving Gel 
 
40 % Acrylamide 
 
1.5 ml 11.25 ml 15 ml 18 ml 
0.5 M Tris-HCl 
(pH 6.8)/1% SDS 
 
3.75 ml -- -- -- 
1.5 M Tris-HCl 
(pH 8.8)/1% SDS 
 
-- 15 ml 15 ml 15 ml 
Nano pure water 
 
9.50 ml 33.75 30 ml 27 ml 
10% ammonium 
persulfate 
(prepared fresh) 
 
300 µl 300 µl 300 µl 300 µl 
TEMED 
 
30 µl 30 µl 30 µl 30 µl 
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use of SDS-PAGE allows separation of proteins by molecular weight.  This technique 
allows for greater resolution of discrete proteins.  Here, 2D PAGE was used to investigate 
the proteome of OhILAs grown under varying conditions.  Prior to 2D PAGE, samples 
underwent TCA precipitation as previously described.  The remaining pellet was 
resuspended in 100 µl of 2D lysis buffer.  Protein yield and concentration were 
determined as previously described. 
 A volume equal to the recommended amount of protein as noted throughout was 
diluted to either 125 µl (7cm strips) or 200 µl (11 cm strips) as noted in a buffer 
(rehydration buffer) containing 7M urea, 2M thiourea, 4% CHAPS, 10 mM DTT, a trace 
amount of bromophenol blue (Fisher Scientific) and 1/100 volume 100X Bio-Lyte 3-10 
carrier ampholytes (20%) (BioRad).  The bromophenol blue served as a dye front to track 
progress of the isoelectric focusing.  Immobilized pH gradient (IPG) strips of pH range 3 
to 10 were purchased from BioRad Laboratories in lengths of 7 cm (catalog # 163-2000) 
or 11 cm (catalog # 163-2014) as noted throughout.  Isoelectric focusing was performed 
in the IEF Cell (catalog # 165-4000) from BioRad laboratories.  Electrodes were covered 
w/ filter paper which was saturated with 10 µl of nano pure water.  The sample was 
pipetted along the edge of the channel.  The plastic covering was removed from the strip 
and the strip was then placed gel side down on top of the sample.  The strips were 
covered with an appropriate volume of mineral oil.  Rehydration and sample loading 
were done using active rehydration at 50 volts for 12 hours.  Following rehydration, the 
strips were focused using the parameters as detailed in Table 2. 
 Following isoelectric focusing the strips were equilibrated for ten minutes in 
equilibration buffer 1 containing in 20 ml 6 M urea, 2% SDS, 0.375 M Tris-HCl (pH 
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Table 2:  Isoelectric focusing guidelines for pH 3-10 strips.  Adapted from ReadyStrip IPG Strip Instruction 
Manual 
 7 cm 11 cm 
Start Voltage 0 V 0 V 
End Voltage 4,000 V 8,000 V 
Volt-hours 10,000 35,000 
Ramp Rapid Rapid 
Temperature 20o C 20o C 
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8.8), 20 % glycerol and 2% DTT followed by equilibration for ten minutes in 
equilibration buffer 2 containing in 20 ml 6 M urea, 2% SDS, 0.375 M Tris-HCl (pH 
8.8), 20 % glycerol, 2% DTT and 0.5 g iodoacetamide (Acros Organics; FW 184.96).  
The strips were then soaked in 100 ml of running buffer and transferred to a resolving gel 
(percent acrylamide specified throughout); either a 7 cm pre-cast or a large format 16 cm 
gel prepared as previously described.  The strip was overlayed with overlay agarose of 
the following composition: 25 mM Tris, 192 mM glycine, 0.1 % SDS, 0.5% low melting 
point agarose (Fisher Scientific).  Proteins were separated by molecular weight as 
previously described. 
 
Staining of proteins using Coomassie Brilliant Blue R-250 
 To visualize proteins, gels containing >30 µg of protein per lane were stained 
using the Coomassie Brilliant Blue technique (Coomassie stained).  Gels were soaked 
overnight in a dye solution containing in 500 ml 0.12 g brilliant blue (Fisher Scientific), 
125 ml methanol (Fisher Scientific), 50 ml glacial acetic acid (Fisher Scientific) and 
brought to volume with nano pure water.  Following the staining procedure, gels were 
soaked in a 10% glacial acetic acid solution until bands resolved.  Addition of one or two 
KimWipes in the container speeded destaining procedure.  Gels were imaged in Kodak 
1D ver 3.5.4 LE software using a Kodak DC290 camera housed in a Kodak EDAS 290 
housing.  A Fisher Scientific light source (model # DLT-A) provided the lightsource.  
Unless otherwise noted, exposure times were 1/250 of a second.  Gels were then dried for 
3 hours (7 cm) or 5.5 hours (16 cm) at 60oC with a slab gel dryer (model # SGD4050) 
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and gel pump (model # GP100) from Savant.  Fresh calcium chloride (Fisher Scientific 
catalog; FW 110.99) was used as dessicant. 
 
Staining of proteins using silver salts 
 To visualize proteins, gels containing < 5 µg of protein per lane were stained 
using the following silver stain protocol.  Immediately following SDS-PAGE, gels were 
removed to a fresh solution of 40% methanol (Fisher Scientific) and 7.41% formaldehyde 
(Sigma Aldrich) in distilled water for twenty minutes (7cm) or one hour (16 cm).  Gels 
were then thoroughly washed with distilled water before soaking in a 0.02% sodium 
thiosulfate (Sigma Aldrich; FW 158.1) solution for two minutes.  Gels were washed two 
times for twenty seconds per wash.  Gels were then soaked in a 0.1% silver nitrate 
(Sigma Aldrich; FW 169.9) solution for ten minutes.  Gels were washed with water and 
with a small volume of developing solution containing in one liter 30 g sodium carbonate 
(Fisher Scientific; FW 105.99) 1.35 ml 37% formaldehyde and 4 mg of sodium 
thiosulfate.  Gel was then placed in developing solution until faint bands began to appear.  
Addition of 5 ml 2.3 M citric acid (Fisher Scientific; FW 192.13) per 100 ml developing 
solution slowly stopped the developing reaction.  Gels were then soaked in a drying 
solution of 30% ethanol and 4% glycerol in distilled water prior to imaging and drying as 
previously described. 
 
In gel assay of arsenate reductase activity 
 To qualitatively assay for arsenate reductase activity, and in gel activity assay was 
conducted.  Native SDS-PAGE gels were run as previously described.  The gel was then 
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soaked in a reduced methyl viologen buffer containing 10 mM Tris-HCl (pH 8.0) and 5 
mM methyl viologen (Sigma Aldrich; FW 257.17).  The methyl viologen was reduced 
with 0.25 g of sodium dithionite (Sigma Aldrich; FW 174.1) to form a brilliant blue 
color.  After the gel was sufficiently stained, the reduced methyl viologen solution was 
removed and the gel was washed in a 5 mM arsenate buffer containing 10 mM Tris-HCl 
(pH 8.0) and 5 mM sodium arsenate (Sigma Aldrich; FW 312.02) until clear bands began 
to appear where reduction was occurring.  The gel was immediately imaged as previously 
described.  The gel was subsequently coomassie stained, imaged and dried. 
 
In vitro assay of arsenate reductase activity 
 To quantify the arsenate reductase activity present in the protein samples, an in 
vitro assay was performed.  A MVr buffer solution containing 300 µM methyl viologen, 
1.3 mM sodium arsenate and 10 mM Tris-HCl (pH 8.0) was degassed using argon 
(Airgas) and reduced with 50 µl of a buffer containing 0.575 M dithionite also under 
argon atmosphere.  Starna Cell anaerobic 1.5 ml quartz cuvettes with a 1 cm pathlength 
were degassed with argon.  1 ml of the reduced 300 µM MV buffer was anaerobically 
transferred to the cuvette using a 3 ml syringe. 
 Native protein suspensions were diluted to a 1 µg/ µl concentration in lysis buffer 
1.  Caps were briefly removed and 5 µl of protein suspension (experimental) or lysis 
buffer 1 (control) were added to the cuvette, which was immediately recapped.  
Absorbance at 600 nm was monitored for ten minutes.  A MVox buffer solution 
containing 300 µM methyl viologen, 1.3 mM sodium arsenate and 10 mM Tris-HCl (pH 
8.0) was used as reference.  As control, this method was repeated using arsenate free 
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MVr and MVox buffers.  Activity curves were constructed as detailed in results.  Specific 
activity was calculated from the linear portion of the curves using the equation  
 
where the extinction coefficient for reduced methyl viologen is equal to 13.1 L mole-1 
cm-1. 
 
Western blot for ArrA1 
 As detailed by Thangavelu (2004), a synthetic peptide corresponding the the C-
terminus of ArrA1 from Bacillus selenitereducsens  (N-KCYGQGHWAYGHIAS-C) was 
used to raise polyclonal antibodies in two rabbits.  The antibody, anti-ArrA1, was then 
affinity purified using ArrA1 as the ligand.  The synthetic peptide from B. 
selenitereducsens has 73% identity to the C-terminus of OhILAs ArrA1 (Schaeffer et al., 
2001)(Altschul et al., 1997).   
To assay for the presence of ArrA1, a Western blot was conducted using a heat 
denatured SDS-PAGE gel with TCA precipitated samples.  After the gel was run, a 
blotting sandwich was prepared by soaking the gel, two gel size pieces of Ahlstrom 
Filtration 0.83 mm filter paper (Fisher Scientific), a piece of GE Water & Process 
Technologies 0.45 micron NitroBind nitrocellulose membrane (Fisher Scientific) cut to 
gel size and two sponges in a transfer buffer containing in one L 14.4 g glycine, 3.03 g 
Tris and 100 ml methanol (pH 8.3) until saturated.  Handling the nitrocellulose with 
forceps, the blotting sandwich was prepared.  The sandwich was placed into a BioRad gel 
box and chamber was filled with transfer buffer.  An ice pack and magnetic stir bar were 
used to cool set-up during transfer.  Proteins were transferred at 250 mA for 30 minutes. 
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 After transfer, gel was Coomassie stained as previously described.  Nitrocellulose 
was incubated at ambient temperature in Killer Filler containing in one liter 5 g casein 
(Sigma Aldrich), 0.01 M sodium hydroxide (Fisher Scientific; FW 40.00), 900 ml 
phosphate buffered solution (appendix 1), 5 g bovine serum albumin (Sigma Aldrich), 0.1 
g phenol red  and 1.8 g sodium azide (Sigma Aldrich; FW 65.01) (pH 7.4) for two hours.  
The nitrocellulose membrane was then incubated overnight in a primary antibody 
solution containing anti-ArrA1 (appendix 1) affinity purified from rabbit serum in Killer 
Filler at a 1:1000 dilution.  The membrane was washed twice in a TTBS solution 
containing in one liter 9 g sodium chloride, 6.05 g Tris-HCl (pH 7.5) and 0.5 ml Tween-
20 (Fisher Scientific) followed by washing two times with a TBS solution containing 9 g 
sodium chloride and 6.05 g Tris-HCl (pH 7.5).  The membrane was incubated for a 
minimum of two hours in secondary antibody (anti-Rabbit) and again washed twice each 
with TBS and TTBS. 
 The membrane was developed by combining solution 1 (7.5 mg 5-bromo-4-
chloro-3-indolyl phosphate dissolved in 0.5 ml dimethyl formamide (Sigma Aldrich) with 
solution 2 (15 mg Nitro Blue tetrazolium (Sigma Aldrich catalog # N-6876; FW 817.6) 
dissolved in 0.35 ml dimethyl formamide and 0.15 ml distilled water) in 50 ml of 
carbonate buffer containing 8.4 g sodium bicarbonate and 0.2 g magnesium chloride in 
one liter (pH 9.8).  The solution was poured over the membrane, which was allowed to 
develop for the specified time in darkness. 
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In vitro assay for sodium dependent transformation of roxarsone. 
To develop an assay to monitor the disappearance of roxarsone in vitro, whole 
cell suspensions were obtained as previously described and suspended in a 10 mM Tris-
HCl (pH 8.0) buffer.  Anaerobic cuvettes containing 1 ml of a buffer containing 10 mM 
Tris-HCl (pH 8.0), 100 µM roxarsone, and the specified concentration of sodium chloride 
were degassed with hydrogen and sealed.  100 µl of the whole cell suspension was added 
to the reaction mixture and absorbance at 400 nm was recorded at the specified time 
points. 
Upon completion, the 600 nm absorbance of each sample was recorded, and 
whole cells were removed from the sample using a 0.22 µm filter as previously detailed.  
A full-wavelength scan was then performed on the remaining filtrate.  The data was 
graphed in GraphPad Prism 5.0. 
 
Full wavelength scans of roxarsone, 2-nitrophenol and proposed metabolites 
 To develop a reliable activity spectrophotometric activity assay to monitor the 
disappearance of roxarsone and the structurally similar 2-nitrophenol, full wavelength 
scans of these compounds and the proposed metabolites, 3-A-4-HBAA and 2-
aminophenol, were needed to establish peak absorbance.  1 mM stock solutions of the 
above mentioned compounds prepared in 10 mM Tris-HCl (pH 7.3) were diluted to 100 
µM concentrations.  A full wavelength scan was performed from 250 nm to 900 nm.  The 
results were plotted in GraphPad Prism 5.0. 
 
47 
In vitro assay to assay concentration of 3-A-4-HBAA or 2-aminophenol 
 The primary metabolites expected from the transformation of roxarsone or the 
structurally similar 2-nitrophenol are 3-A-4-HBAA or 2-aminophenol respectively.  Full 
wavelength spectra have demonstrated that 3-A-4-HBAA has minimal impact at the peak 
absorbance for roxarsone, 400 nm.  However, full wavelength data obtained on 2-
nitrophenol and 2-aminophenol indicate that there may be interference near the peak 
absorbance for the respective compounds.  To accommodate for this, a colorimetric assay 
detecting amino compounds, development of an assay to monitor the concentration of 
both 3-A-4-HBAAs began.  This method was adapted from the assay for aminobenzoate 
(Rafil et al., 1991) 
To produce a standard curve for each of the compounds, 1 mM stock solutions of 
3-A-4-HBAA and 2-aminophenol were prepared in 10 mM Tris-HCl (pH 8.0) buffer.  
The 1 mM stock solutions were diluted to either a 100, 50, 25 or 10 µM final 
concentration in 10 mM Tris-HCl buffer in a final volume of 1 ml.  To this volume, 200 
µl of 2.1% (w/v) trichloroacetic acid and 20 µl of 0.7% sodium nitrite were added.  The 
reaction was incubated for twenty minutes at ambient temperature.  20 µl of 4% (w/v) 
ammonium sulfamate was added to the reaction.  Following a 3 minute incubation at 
room temperature, 700 µl of 1% NEDD was added to the reaction, which was then 
incubated for 35 minutes.  Addition of 60 µl 10 mM Tris-HCl (pH 8.0) brought the final 
volume to 2 ml. 
Absorbance of the final reaction product at 543 nm was recorded (Rafil et al., 
1991) and plotted against the concentration of the organoarsenical.  Extinction 
coefficients for 3-A-4-HBAA (ε = 11.03 L mole-1 cm-1) and 2-aminophenol (ε = 3.11 L 
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mole-1 cm-1) were calculated from the slope of the standard curve.  As control, the same 
procedure was followed starting with 1 mM stock solutions of either roxarsone or 1 mM 
2-nitrophenol.  Extinction coefficients associated with these compounds were negligible. 
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Results 
 
Establishing the roxarsone  extinction coefficient 
 To develop a spectrophotometric assay to monitor concentrations of 3-nitro-4-
hydroxy benzene arsonic acid, a standard curve was established at 400 nm (Figure 7).  It 
has been previously been established that roxarsone has a peak absorbance in the visible 
range, near 400 nm.  Furthermore, it has also been previously established that the 
expected products, those of 3-A-4-HBAA and 4-hydroxybenzene arsonic acid, have 
minimal absorbance at this wavelength (Fisher, 2006). 
 A standard curve of roxarsone (Figure 1) was established using a one millimolar 
stock solution that was diluted to the following concentrations:  500, 250, 150, 100, 50, 
and 25 micromolar.  Absorbance was recorded for the samples at 400 nm and the data 
was graphed in GraphPad Prism 5.0.  An extinction coefficient (ε) was calculated from 
the slope of the linear regression (ε = 2.841 mM-1cm-1).  All calculations were performed 
in GraphPad Prism 5.0. 
 
 
Aerobic chicken litter enrichments do not transform 3-nitro-4-hydroxybenzene arsenic 
acid 
 Previous evidence from our lab and others has shown that anaerobic cultures of 
chicken litter enrichments are capable of transforming roxarsone.  However, there is no 
present study investigating the role aerobic cultures may play in this same phenomenon.  
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Figure 7:  Standard curve of roxarsone concentration.  A one millimolar stock solution was diluted to 
the following concentrations:  500, 250, 150, 100, 50, and 25 micromolar.  Absorbance = 400 nm, ε = 2.841 
mM-1cm-1 (r20.9927).  Prepared in GraphPad Prism 5.0.  Calculations performed using linear regression. 
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To investigate whether microbial cultures obtained from a chicken litter enrichment were 
capable of transforming roxarsone aerobically, enrichment cultures were grown on 
aerobic OhBs media using lactate as the initial carbon source.  Cultures were inoculated 
with one milliliter of slurry and incubated at ambient temperature throughout the duration 
of the experiment. 
 Samples were collected initially and continued at intervals throughout the 
duration of the experiment.  Aerobic cultures demonstrated growth as expected in the 
presence of 3-nitro-4-hydroxybenzene arsonic (1 mM) acid as well roxarsone (1 mM) and 
sodium lactate (10 mM) as measured spectrophotometrically at 600 nm  (Figure 8).  
Understandably, there was an increased cell yield in cultures grown in the presence of 
lactate than in those grown in its absence (Figure 8).  However, there was no 
transformation of roxarsone observed as determined by the spectrophotometric assay at 
400 nm in either the lactate cultures or the cultures without lactate (Figure 8).  These data 
suggest that the rapid transformation of roxarsone seen previously (Garbarino et al., 
2003); (Morrison, 1969); (Gupta & Charles, 1999); (Rosal et al., 2005); (Rutherford et 
al., 2003) is likely the result of biotransformations occurring under anaerobic conditions.  
In contrast, Brown et al (2005) detected 5% transformation of roxarsone in cultures 
treated with Ap (top horizon) soil of the Frederick soil profile at pH 5.  
 
Clostridium sp. strain OhILAs demonstrates increased growth in the presence of 3-nitro-
4-hydroxy benzene arsonic acid. 
Previous evidence has suggested that Clostridium sp. strain OhILAs is able to 
transform the organoarsenical 3-nitro-4-hydroxybenzenearsonic acid (roxarsone) when  
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Figure 8:  Aerobic growth of chicken litter enrichments in the presence of roxarsone.  Growth 
(determined at 600 nm) is increased in the presence of lactate (■) compared to cultures grown in the 
presence of roxarsone alone (●).  No change in roxarsone was seen as determined at 400 nm (▲).  Aerobic 
OhBs media was prepared as detailed in “Materials and Methods” and amended to 1 mM roxarsone and, 
where indicated, 10 mM lactate.  Concentration of roxarsone determined as described in “Materials and 
Methods” using ε = 2.84 mM-1 cm-1 as measured previously.  Error bars represent standard error of the 
mean (SEM) as calculated from triplicate cultures. 
 
Reproduced in part with permission from Stolz, J. F., Perera, E., Kilonzo, B., Kail, B., Crable, B., Fisher, 
E., Ranganathan, M., Wormer, L. & Basu, P.  Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid 
(roxarsone) and release of inorganic arsenic by Clostridium species. Environ Sci Technol, 41, 818-23.  
Copyright 2007 American Chemical Society. 
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grown anaerobically (Stolz et al 2007).  The primary metabolite from this anaerobic 
transformation is a similar compound, 3-A-4-HBAA, where the nitro group on the third 
carbon has been reduced to an amine group (Stolz et al 2007).  These results suggest that 
the organism may be using roxarsone as a terminal electron acceptor in anaerobic 
respiration. 
To test whether OhILAs is capable of respiring roxarsone, cultures containing 10 
mM of either fructose or lactate were grown in the presence or absence of roxarsone (1 
mM) on OhBs media under a nitrogen atmosphere at ambient temperature.  Samples were 
taken initially and at subsequent intervals throughout the growth phase of the organism to 
a final time point of 72 hours.  The samples were analyzed spectrophotometrically at 600 
nm for turbidity.  Mid-log phase for the cultures was reached at approximately 48 hours 
for cultures grown on lactate in the presence of roxarsone and approximately 36 hours for 
those grown on fructose in the presence of roxarsone (Figure 9).  The cultures grown in 
the absence of roxarsone did not reach mid-log phase in the 72 hour time span (Figure 9).  
These data indicate that OhILAs shows significantly increased growth when grown in the 
presence of roxarsone when compared to cultures grown in the absence of roxarsone (p < 
0.05) (Figure 9).  Additionally, visual colorimetric observation indicated that the 
roxarsone disappeared as the cultures were allowed to grow (data not shown).  No growth 
or disappearance of roxarsone was seen in abiotic controls (data not shown). 
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Figure 9:  OhILAs demonstrates increased growth in presence of roxarsone.  Cultures were grown on 
anaerobic OhBs media  under an atmosphere of nitrogen at ambient temperatures in the presence (1 mM) or 
absence (0 mM) of roxarsone for either lactate (A) or fructose (B).  Samples were taken initially and at time 
points indicated to a total of 72 hours.  Means represent data obtained from three experimental cultures.  No 
growth was seen in abiotic controls (not shown).  Anaerobic OhBs media was prepared as detailed in 
“Materials and Methods” and amended to 1 mM roxarsone and, where indicated, 10 mM lactate or 10 mM 
fructose.  Data plotted in GraphPad Prism 5.0.  Error bars represent standard error of the mean (SEM) as 
calculated from triplicate cultures. 
 
Reproduced in part with permission from Stolz, J. F., Perera, E., Kilonzo, B., Kail, B., Crable, B., Fisher, 
E., Ranganathan, M., Wormer, L. & Basu, P.  Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid 
(roxarsone) and release of inorganic arsenic by Clostridium species. Environ Sci Technol, 41, 818-23.  
Copyright 2007 American Chemical Society. 
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These data, coupled with the previous findings that OhILAs transforms roxarsone into 3-
A-4-HBAA, suggest a role for roxarsone as a terminal electron acceptor during anaerobic 
respiration.  Reducing equivalents generated during glycolysis are fed into the electron 
transport chain.  These electrons generate an electrochemical gradient as they are passed 
along the chain, and are ultimately passed to the nitro group on the third carbon of 
roxarsone; subsequently reducing it to an amine group.  This generates ATP via oxidative 
phosphorylation, resulting in increased growth of the organism. 
 
Clostridium sp. strain OhILAs transforms the structurally similar 2-nitrophenol, but not 
4-nitrophenol 
As demonstrated previously, the nitro group on the third carbon of 3-nitro-4-
hydroxybenzenearsonic acid (roxarsone) is reduced to an amine group producing the 
reduced compound, 3-A-4-HBAA acid (Stolz et al 2007).  It is interesting to note that 
roxarsone, however, contains two oxidizing groups on its aromatic ring:  the nitro group 
on the third carbon as well as the arsenate group on the first carbon.  Evidence 
demonstrating OhILAs reduces only the nitro group suggests that the enzyme responsible 
for the initial reduction of a nitro to an amine is specific for a nitro group, and is not able 
to reduce the arsenate group. 
To examine the specificity of the enzyme involved, transformation of the 
structurally similar compounds 2- and 4-nitrophenol was examined.  Cultures of 
Clostridium sp. strain OhILAs grown on OhBs containing the presence (1 mM) or 
absence (0 mM) of one of the nitrophenolic compounds and/or the presence of lactate (10 
mM) were grown under a nitrogen atmosphere at ambient conditions.  Samples were 
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taken initially and every twelve hours thereafter for 72 hours.  Samples were analyzed 
spectrophotometrically for turbidity at 600 nm.  The 2-nitrophenol cultures reached mid-
log phase prior to the 24 hour timepoint (Figure 10).   
Transformation of 2-nitrophenol and 4-nitrophenol was monitored 
spectrophotometrically at the compound’s peak absorbance; 410nm and 400nm 
respectively.  Zeyer et al (1986) have previously established an extinction coefficient for 
2-nitrophenol (ε = 3.47 mM-1cm-1 at 410 nm).  From this, the concentration of 2-
nitrophenol in solution was calculated using Beer’s Law as previously detailed. 
Consistent with the prediction that the enzyme responsible will reduce the nitro 
group located ortho to the hydroxyl group, the samples showed a corresponding decrease 
in 2-nitrophenol concentration (Figure 10) suggesting that the organism is capable of 
reducing the nitro group located in a position analogous to its location on the aromatic 
ring of roxarsone.  Interestingly, the results of the same experiment conducted using 4-
nitrophenol showed minimal transformation (data not shown). 
Similarly, OhILAs grown on OhBs media amended with 10 mM lactate and 1 
mM 2-nitrophenol show a similar physiological response to the nitro aromatic as the 
organism grown in the presence of roxarsone (Figure 11).  Anaerobic cultures of OhILAs 
were grown in the presence of 10 mM lactate and either 1 mM 2-nitrophenol or 1 mM 
roxarsone.  The absorbance at 600 nm or samples taken initially and at intervals 
throughout the experiment suggest that the physiological response of OhILAs grown in 
the presence of 2-nitrophenol is similar to OhILAs grown in the presence of roxarsone 
and provide further evidence to suggest that reduction of the nitro group is linked to 
respiratory processes. 
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Figure 10:  Growth curves of OhILAs in the presence or absence of lactate and 2-nitrophenol.  Pure 
culture of OhILAs grown on OhBs amended to 1 mM 2-nitrophenol in the presence (A) or absence (B) of 
10 mM lactate.  Growth of OhILAs (■) as monitored at 600 nm coincides with disappearance of 2- 
nitrophenol (▼) concentration.  Anaerobic OhBs media prepared as detailed in “Materials and Methods” 
and amended to 1 mM 2-nitrophenol and, where indicated, 10 mM lactate.  Transformation monitored at 
410 nm and converted to concentration using ε = 3.47 mM-1cm-1 (Zeyer et al., 1986).  Error bars 
represent standard error of the mean (SEM) as calculated from triplicate cultures. 
 
 
Adapted with permission from Stolz, J. F., Perera, E., Kilonzo, B., Kail, B., Crable, B., Fisher, E., 
Ranganathan, M., Wormer, L. & Basu, P.  Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid 
(roxarsone) and release of inorganic arsenic by Clostridium species. Environ Sci Technol, 41, 818-23.  
Copyright 2007 American Chemical Society. 
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Figure 11:  Physiological response – 2-nitrophenol.  OhILAs grown in presence of 10 mM lactate and 1 
mM 2-nitrophenol (■) is similar to OhILAs grown in presence of 10 mM lactate and 1 mM roxarsone (♦) as 
monitored at 600 nm.  Roxarsone disappearance (◊) monitored at 400 nm and converted to mM 
concentration using ε = 2.84 mM-1cm-1  as previously described.  Anaerobic OhBs media was prepared as 
detailed in “Materials and Methods” and amended to 1 mM 2-nitrophenol or 1 mM roxarsone and 10 mM 
lactate.  Data plotted in GraphPad Prism 5.0.  Error bars represent standard error of the mean (SEM) as 
calculated from triplicate cultures. 
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Clostridium sp. strain OhILAs does not demonstrate increased growth in the presence of 
3-A-4-HBAA or 4-hydroxybenzene arsonic acid 
While the primary metabolite of roxarsone is 3-A-4-HBAA, it only accounts for 
about 70% of the roxarsone that disappears.  The remaining metabolite composition can 
be accounted for with the production of arsenate and, to a lesser extent, arsenite.  This 
suggests a number of possibilities involved in the mechanism, including further 
transformation of 3-A-4-HBAA. 
To test whether OhILAs was capable of growing in the presence of intermediates 
in the proposed pathway of roxarsone breakdown, OhILAs was grown anaerobically in 
the presence of 10 mM lactate and 1 mM of either 3-A-4-HBAA or 4-hydroxybenzene 
arsonic acid (Figure 12).  These data clearly demonstrate that OhILAs does not exhibit 
increased increased cell yield in the presence of these intermediaries.  This might suggest 
that further transformation of 3-A-4-HBAA either does not occur and that the initial 
production of arsenate is directly from 3-nitro-4-hydroxy benzene arsonic acid, or that 
further transformation of 3-A-4-HBAA occurs through physiological or environmental 
changes brought about by the transformation of roxarsone.  
 
Annotated OhILAs genome – genes of interest 
 The genome of this organism is nearing completion.  With the most recent 
draft genome available, several key proteins were identified that are of interest in 
elucidating the mechanism behind the metabolic breakdown of roxarsone (Table 3).  
Among these, OhILAs contains sequences which potentially encode both the resistance 
arsenate reductase (ars) as well as the respiratory arsenate reductase (arr) pathway.   
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Figure 12:  Growth of OhILAs in presence of proposed intermediates.  OhILAs was grown 
anaerobically on OhBs media amended with 10 mM lactate and 1 mM of either roxarsone (●), 3-A-4-
HBAA (■) or 4-hydroxybenzene arsonic acid (▲).  Anaerobic OhBs media was prepared as detailed in 
“Materials and Methods” and amended to 1 mM  of either 3-A-4-HBAA or 4-hydroxybenzene arsonic acid 
and 10 mM lactate.  Growth represents absorbance at 600 nm.  Data plotted in GraphPad Prism 5.0.  Error 
bars represent standard error of the mean (SEM) as calculated from triplicate cultures. 
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Table 3:  Potential protein targets for understanding the mechanism of roxarsone transformation.  
Molecular Weight (MW) and isoelectric point (PI) calculated using ExPASY suite. 
 Contig Gene Function MW PI 
 ars Operon   Resistance   
arsA 110 1081 ATP-ase 64515.47 5.24 
arsB (acr3) 110 1085 AsIII pump 39260.95 8.34 
arsC 110 1084 AsV reductase 14757.89 5.19 
arsD 110 1080 regulatory 5108.07 8.61 
arsR 110 1083 regulatory 14195.72 5.78 
      
arr  Operon   Respiration   
arrB 110 1068 FeS 24877.08 5.60 
arrA 110 1067 catalytic  99529.29 6.82 
arrC 110 1066 anchoring 22436.11 5.54 
arsM 110 1065 methylase 28353.28 5.08 
      
PETN reductase 109  Degradation   
nemA  860 oxidoreductase 39346.71 5.48 
nemA  891 xenobiotic reductase 37899.45 5.85 
      
Nitroreductase   Nitroreduction   
 83 2219 nitroreductase 22980.53 6.24 
 111 1447 nitroreductase 19250.29 7.01 
 108 667 nitroreductase 26297.81 8.96 
      
F0F1 ATPase   Respiration   
atpA 81 2183 alpha 55550.78 5.32 
atpB 81 2181 beta 49939.99 4.90 
atpG 81 2182 gamma 32320.81 8.94 
atpH 81 2184 delta 20397.80 5.17 
atpC 81 2180 epsilon 15155.29 5.58 
atpI 81 2187 a 25271.27 7.95 
atpF 81 2185 b 25271.27 7.95 
atpE 81 2186 K 8752.42 5.11 
      
Acrylate pathway      
lactate dehydrogenase 
(FMN Dependent) 
110 1125  36029.88 6.96 
Malate/lactate 
dehydrogenases 
85 2263  46789.45 5.70 
pyruvate-ferredoxin 
oxidoreductase 1 
110 1014  66961.19 5.67 
pyruvate-ferredoxin 
oxidoreductase 2 
112 1563  64845.71 5.78 
pyruvate-ferredoxin 
oxidoreductase 3 
70 1984  65280.46 5.71 
phosphotransacetylase 111 1309  32110.46 5.48 
phosphotransacetylase 91 2438  32405.83 5.16 
acetate kinase 97 2595  43234.64 5.55 
      
Stickland Ferment      
Glycine reductase 74 2041  4555.30 4.72 
Glycine reductase 74 2043  38101.30 5.00 
Glycine reductase 74 2044  8250.76 6.73 
Glycine reductase 90 2399  69036.25 5.04 
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Investigations into the activity of the arsenate reductase have suggested that OhILAs 
might maintain constitutive expression of these proteins.  Using reduced methyl viologen 
as an electron donor, a colorimetric in vitro activity assay was conducted.  Oxidation of 
methyl viologen was monitored spectrophotometrically in the presence or absence of 
arsenate as an electron acceptor.  The data demonstrate that under all growth conditions, 
both soluble and insoluble fractions were capable of oxidizing the methyl viologen in the 
presence of arsenate, but not in its absence. 
 
In gel arsenate reductase assay suggests arsenate reductase is constitutively expressed 
 Ultimately, the concern lies with the production of inorganic arsenic from the 
transformation of roxarsone.  As mentioned earlier, the primary metabolite is 3-A-4-
HBAA, though the remaining mass can be accounted for with production of arsenate and, 
to a lesser extent, arsenite.  Previous evidence demonstrates that the initial form of 
inorganic arsenic is in the form of arsenate, and that later there is production of arsenite.  
This suggests that the production of arsenite is from respiration of arsenate. 
 The annotated genome of OhILAs reveals genes encoding the components of the 
respiratory arsenate reductase pathway, as well as those coding for the resistance pathway 
discussed previously.  In gel activity assays using reduced methyl viologen as an electron 
donor were used to qualitatively assay for expression of arsenate reductase.  Methyl 
viologen is a useful indicator that changes color between reduced and oxidized forms.  
Reduced methyl viologen is blue in color.  When the reduced methyl viologen donates 
two electrons to arsenate, forming arsenite, the oxidized methyl viologen is clear in color.   
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A buffer containing 1 mM methyl viologen in 10 mM Tris-HCl (pH 8.0) was 
reduced with 0.25 g sodium dithionite.  A native 12% SDS-PAGE gel (Figure 13) 
containing 35 µg soluble (1-4) and insoluble (5-8) OhILAs protein fraction grown on 10 
mM lactate (1,5) or 10 mM lactate and 1 mM of either roxarsone (2,6), 2-nitrophenol 
(3,7) or or 5 mM sodium arsenate (4,8).   
The gel was run as described earlier and stained in the 1 mM methyl viologen 
solution reduced with sodium dithionite for fifteen minutes.  The methyl viologen 
solution was removed, and the gel was then washed with a 5 mM sodium arsenate 
solution in 10 mM Tris-HCl (pH 8.0) buffer.  An approximately 75 kDa protein band in 
the gel showed observable clearings in all fractions (Figure 13) when washed with the 
sodium arsenate solution.  This suggests that an enzyme present was transferring 
electrons from the reduced methyl viologen to the arsenate (forming arsenite).  Since 
methyl viologen autooxidizes, the gel was imaged immediately (Figure 13) as previously 
detailed.  
 
In vitro arsenate reductase assay suggests arsenate reductase is constitutively expressed 
The results of the in gel assay suggest that arsenate reductase is constitutively 
expressed.  To quantify the specific activity in the samples, protein fractions were diluted 
to a 1 µg/µl suspension.  A buffer containing 300 µM methyl lviologen, 1.3 mM sodium 
arsenate and 10 mM Tris-HCl (pH 8.0) under argon was reduced with sodium dithionite 
under argon.  One milliliter was anaerobically transferred to an argon degassed cuvette.  
Five micrograms of protein was added to the reaction mixture by quickly removing the  
64 
 
Figure 13:  Arsenate reductase in gel assay.  12% native gel stained with 1 mM reduced methyl viologen 
in 10 mM Tris-HCl (pH 8.0) and washed with 5 mM sodium arsenate in Tris-HCl (pH 8.0) (A) shows 
oxidation of reduced methyl viologen (clearing) in both soluble (1-4) and insoluble (5-8) fractions of 
OhILAs grown on 10 mM lactate (1,5) or 10 mM lactate and 1 mM of either roxarsone (2,6), 2-nitrophenol 
(3,7) or or 5 mM sodium arsenate (4,8).  (B) Gel from A after Coomassie staining showing that clearing is 
associated with approximately 75 kDa band. 
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cap and pipetting in the required volume.  Using the oxidized methyl viologen buffer as 
reference, the oxidation of methyl viologen was followed at 600 nm Specific activity was 
calculated using ε = 13.1 for reduced methyl viologen. 
 Activity was observed in cytosolic (soluble) (Figure 14) OhILAs protein fraction 
grown on 10 mM lactate (Figure 14A) or 10 mM lactate and 1 mM of either roxarsone 
(Figure 14B), 2-nitrophenol (Figure 14C) or or 5 mM sodium arsenate (Figure 14D).  
Additionally, activitity was also observed in the membrane, or insoluble, fraction grown 
on 10 mM lactate (Figure 15A) or 10 mM lactate and 1 mM of either roxarsone (Figure 
15B), 2-nitrophenol (Figure 15C) or 5 mM sodium arsenate (Figure 15D).  No activity 
was observed in samples where a 300 µM methyl viologen buffer in 10 mM Tris-HCl 
(pH 8.) was reduced with sodium dithionite without the presence of arsenate (data not 
shown).  This suggests that an enzyme is indeed involved in oxidation of methyl viologen 
by transferring two electrons to arsenate and forming arsenite. arsenate to arsenite.   
Though enzymes generally tend to be specific for a particular substrate, it is not 
outside the realm of possibility that, with an oxidizer and a reducer present in such high 
concentrations, there could be non-specific transfer of electrons by promiscuous 
enzymes.  To test whether ArrA1 was present in the samples, the non-denatured fractions 
were run in a 12% acrylamide gel.  Proteins from the gel were then transferred to a 
nitrocellulose filter which was incubated in a blocking solution and then in a 1:1,000 
dilution of primary antibody rabbit anti-ArrA1 overnight.  Following incubation in 
primary antibody, the membrane was washed and incubated using a 1:5,000 dilution of 
the secondary goat anti-rabbit antibody and developed using the alkaline phosphatase  
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Figure 14:  Activity of cytosolic (soluble) fractions.  OhILAs cytosolic protein fractions grown in the 
presence of 10 mM lactate (A) or 10 mM lactate and 1 mM of either roxarsone (B), 2-nitrophenol (C) or 5 
mM sodium arsenate (D).  5 µl of a 1 µg/µl protein suspension was added to 1 ml of a 300 µM methyl 
viologen and 100 mM Tris-HCl  (pH 8.0) in the presence (experimental) or absence (control) of 1.3 mM 
sodium arsenate buffer reduced with sodium dithionite.  Specific activity calculated at an absorbance of 
600 nm as previously detailed using ε = 13.1 mM-1 cm-1 for.  Data plotted in GraphPad Prism 5.0.  Error 
bars represent standard error of the mean (SEM) as calculated from triplicate cultures. 
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Figure 15:  Activity of membrane (insoluble) fractions.  OhILAs soluble protein fractions grown in the 
presence of 10 mM lactate (A) or 10 mM lactate and 1 mM of either roxarsone (B), 2-nitrophenol (C) or 5 
mM sodium arsenate (D).  5 µl of a 1 µg/µl protein suspension was added to 1 ml of a 300 µM methyl 
viologen and 100 mM Tris-HCl  (pH 8.0) in the presence (experimental) or absence (control) of 1.3 mM 
sodium arsenate buffer reduced with sodium dithionite.  Specific activity calculated at an absorbance of 
600 nm as previously detailed using ε = 13.1 mM-1 cm-1 for.  Data plotted in GraphPad Prism 5.0.  Error 
bars represent standard error of the mean (SEM) as calculated from triplicate cultures. 
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reaction.  Results of this Western blot (Figure 16) provide evidence to suggest that 
OhILAs ArrA1 expression is constitutive. 
 
In vitro assay of roxarsone  transformation 
 The annotated OhILAs genome suggests that it encodes several target proteins of 
interest that may be involved in the transformation of roxarsone.  Among these proteins, 
OhILAs contains a region coding for a F1/F0 sodium dependent ATP synthase.  Imkamp 
& Mueller (2002) demonstrated that reduction of caffeate by the bacterium Acetobacter 
woodii was sodium dependent.  Here, preliminary development of an in vitro activity 
assay to determine if transformation of roxarsone is sodium dependent is discussed. 
 Full wavelength scans of 3-nitro-4-hydroxybenzene arsonic, 2-nitrophenol, and 
their proposed metabolites were performed using 100 µM concentrations in 10 mM Tris-
HCl (pH 7.3) (Figure 17).  This data was useful in interpreting the results of subsequent 
activity assays. 
 Interestingly, results of the full wavelength spectral data (Figure 17) suggest that 
monitoring 2-nitrophenol disappearance directly using spectrophotometry is undesirable. 
While 2-nitrophenol has a broad peak absorbance around 410 nm.  However, consistent 
with the results of Gonçalves et al (2000) the spectral data interference at this 
wavelength.  It is suggested that the interference is the result of quinine formation as 
suggested by Gonçalves and colleagues (2000).  To compensate for this, an assay 
measuring the concentration of amine compounds was developed using modification of 
an existing protocol (Rafil et al., 1991). A standard curve of 3-A-4-HBAA and 2-
aminophenol were prepared. 
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Sequence Alignment 
 
Query  1    KCYGQGHWAYGHIAS  15 
            K YGQGHWA GH+A+ 
Sbjct  828  KNYGQGHWAMGHVAA  842 
 
 
 
73% Identity 
 
 
 
Figure 16:  Western blot of ArrA.  Native SDS-PAGE gel (A) indicated that protein fractions of OhILAs 
(1-4) and membrane (5-8) OhILAs protein fractions grown on 10 mM lactate (1,5) or 10 mM lactate and 
either 1 mM roxarsone (2,6), 1 mM 2-nitrophenol (3,7) or 5 mM sodium arsenate (4,8) were consistently 
loaded and positive for arsenate reductase activity (B).  A native gel was  transferred to nitrocellulose 
membrane and blotted using anti-ArrA1 rabbit primary antibody and anti-rabbit goat secondary antibody 
and developed using alkaline phosphatase reaction as detailed in “Materials and Methods” (C).  Polyclonal 
anti-ArrA1 were raised in a rabbit system against a synthetic peptide (Query) corresponding to Bacillus 
selenitereducsens ArrA1 C-terminus (Thangavelu, 2004) which has 73% identity to a fifteen peptide stretch 
of OhILAs ArrA (Sbjct) (D) (Schaeffer et al., 2001)(Altschul et al., 1997).  
A 
C 
B 
D 
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Figure 17:  Full wavelength spectra of roxarsone, 2-nitrophenol, 3-amino-4-hydroxybenzene arsonic 
acid and 2-aminophenol.  100 µM concentrations of roxarsone (A), 2-nitrophenol, (C) and the proposed 
metabolites 3-A-4-HBAA (B) and 2-aminophenol (D) were prepared in 10 mM Tris-HCl (pH 7.3).  Data 
plotted in GraphPad Prism 5.0. 
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To produce a standard curve for each of the compounds, the previously described 
method was applied to 3-A-4-HBAA and 2-aminophenol.  Assay specific extinction 
coefficients for 3-A-4-HBAA (ε = 11.03 L mole-1 cm-1) and 2-aminophenol (ε = 3.11 L 
mole-1 cm-1) were calculated from the slope of the standard curve (Figure 18).  As 
control, the same procedure was followed starting with either roxarsone or 1 mM 2-
nitrophenol.  Extinction coefficients associated with these compounds were negligible 
(data not shown). 
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Figure 18:  Standard curve of amino-organic concentrations prepared as described previously 
(Materials & Methods).  Extinction coefficients (ε) for 3-A-4-HBAA (A) and 2-aminophenol (B) calculated 
from slope.   
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Discussion 
 
 The agricultural revolution has had vast cultural and economic impacts.  Society 
has moved from an age where hunter-gatherers existed on what little was available in the 
forests to an age where acres of fields grow lush with corn, rice and various other 
agricultural staples.  Instead of relying on hunting, with ensuing cycles of feast and 
famine, society is now able to rely on a constant supply of beef, poultry and pork 
products.  There is no argument that this revolution has changed society for the better, 
ensuring better quality and more nutritious diets around the globe.  However, from use of 
toxic pesticides and herbicides to hormonal supplements and feed additives, the United 
States agricultural industry has seen a much wider breadth of questionable compounds 
used in farming.  While the use of some of these compounds may pose no environmental 
or human health risks, it is unsafe and impractical to use compounds until their 
mechanism of action as well as their behavior when released into the environment is fully 
understood. 
 Roxarsone, a feed additive used widely by the poultry industry for growing larger 
birds with better coloration (Abdo, 1989) is a compound that has come under recent 
investigation.  The FDA considers this compound benign in its native state (Salsbury 
Laboratories, 1981), in part because it passes through chickens largely untransformed 
(Anderson &  Chamblee, 2001).  However, increased levels of arsenic found in fields 
treated with litter from chickens fed chicken feed containing roxarsone (Brown et al., 
2005), have prompted further investigation into its behavior when released into the 
environment. 
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 Recent evidence has suggested that roxarsone is rapidly transformed to a 
structurally similar organoarsenical, 3-A-4-HBAA (Stolz et al., 2007); (Cortinas et al., 
2006).  Since this compound is also used in the poultry industry and has long been 
considered benign, more pressing concerns arise when considering the remaining 
metabolites; compounds such as arsenate and, to a lesser extent, arsenite (Cortinas et al., 
2006); (Stolz et al., 2007).  While an exact mechanism of roxarsone transformation has 
yet to be agreed on, the previously mentioned evidence suggests that reduction of the 
nitro group to an amine may be the initial step, followed by successive breakdown, either 
aerobically or anaerobically, of the resulting 3-A-4-HBAA (Figure 5).  This study 
investigates the role of chicken litter enrichment cultures and a pure strain Clostridium 
sp. strain OhILAs in the biotransformation of these compounds.  Additionally, 
investigations into the proteome of OhILAs have revealed proteins that may be of interest 
in understanding the metabolic pathway involved in breakdown of roxarsone. 
 Previous research has suggested that the dominant organisms in anaerobic chicken 
litter enrichment cultures are clostridial species.  Only spore-forming rods were observed 
using light microscopy of the enrichment cultures.  Furthermore, limited diversity of 16s 
rRNA would suggests that clostridia are the dominant organisms of anaerobic chicken 
litter enrichments.  This present study examines the physiology of roxarsone 
transformation by a clostridial species, OhILAs, as well as the ability of chicken litter 
enrichments grown aerobically to transform this organoarsenical. 
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Physiological roles of roxarsone transformation 
 The pattern of roxarsone transformation by OhILAs is similar to that observed 
previously in anaerobic chicken litter enrichment cultures.  Initially, formation of 3-A-4-
HBAA is observed, followed by release of inorganic species.  While the observed initial 
times for these products differes between cultures of OhILAs and the enrichment 
cultures, it is imperative to remain cognizant of the fact that the enrichment cultures are 
mixed cultures, which could delay transformation of roxarsone.  Nonetheless, the pattern 
of transformation between the two cultures remains very similar under these conditions.  
This observation allows further investigation into the physiology of roxarsone 
transformation by OhILAs.  As detailed by Stolz et al (2007), reduction of the nitro group 
to an amine requires six electrons.  This would suggest the following equation: 
 
2 roxarsone + 3 lactate Æ 2 3-A-4-HBAA + 3 acetate + 3 CO2 + H2O 
 
 In anaerobic transformation of roxarsone by both OhILAs as well as anaerobic 
chicken litter enrichments, formation of acetate was observed and was balanced with 
consumption of lactate.  Traditionally, there are two common pathways in which lactate 
is fermented to yield acetate and propionate.  In the succinate-propionate pathway (Figure 
19), three molecules of lactate are oxidized to form three molecules of pyruvate by lactate 
dehydrogenase.  This reaction results in the release of six electrons ([H]).  The molecules 
of pyruvate are then further oxidized to form either acetate or propionate at a ratio of one 
molecule acetate to two molecules propionate.  Conversion of one molecule 
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Figure 19:  Succinate-Propionate Pathway (White, 1995). 
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of pyruvate to acetyl-CoA by pyruvate dehydrogenase results in the release of two 
additional [H].  This acetyl-CoA is then passed through phosphotransacetylase and 
acetate kinase to yield one molecule of acetate (White, 1995). 
 The two remaining molecules of pyruvate are converted to oxaloacetate by 
methylmalonyl-CoA-pyruvate transcarboxylase, a reaction which consumes two [H] per 
molecule of pyruvate.  The oxaloacetates are then converted to malate by malate 
dehydrogenase followed by conversion to fumarate by fumarase.  Consumption of an 
additional two [H] per molecule occurs in the reduction of fumarate to succinate via 
fumarate reductase.  The two molecules of succinate are then converted  are converted to 
two molecules of succinyl-CoA (CoA transferase) and subsequently methylmalonyl-CoA 
(methylmalonyl-CoA racemase).  The resulting methylmalonyl-CoA is then converted to 
proprionyl-CoA when the carboxyl groups are donated to pyruvate via methylmalonyl-
CoA-pyruvate transcarboxylase.  The CoA group of proprionyl-CoA is donated to 
succinate by the CoA transferase resulting in formation of propionate (White, 1995). 
 Genomic analysis has indicated that certain components of this pathway were 
missing.  Crucial among these are malate dehydrogenase and fumarate hydratase.  
Without these components, this metabolic pathway is unable to proceed from the 
oxaloacetate.  Conversely, analysis of the genome has indicated that all necessary 
components of the acrylate pathway are present. 
 In the acrylate pathway (Figure 20), three molecules of latate are oxidized to form 
one molecule of acetate.  Initially, one molecule of lactate is reduced to one molecule of 
pyruvate via the enzyme lactate dehydrogenase.  This reaction results in the release of 
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Figure 20:  Acrylate Pathway (White, 1995). 
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two [H] per molecule of pyruvate produced.  The pyruvate is further oxidized to acetyl-
CoA with the release of carbon dioxide and two additional [H] via pyruvate-ferredoxin 
oxidoreductase.  Ultimately, one molecule of acetyl-CoA  produces one molecule of ATP 
via substrate level phosphorylation as well as production of one molecule acetate.  The 
production of ATP and acetate from acetyl-CoA occurs via a complex two-step process.  
Initially, phosphotransacetylase converts acetyl-CoA to acetyl-P by addition of an 
inorganic phosphate and removal of CoASH.  This intermediary is then converted to 
acetate via acetate kinase with the net result of formation of one molecule of ATP (White, 
1995).   
During fermentation, the reducing equivalents produced during this pathway are 
then passed to additional lactate molecules which have been converted to lactyl-CoA 
using a donated CoA group from proprionyl-CoA and the enzyme CoA transferase.  
Lactyl-CoA is dehydrated to form acrylyl-CoA by an uncharacterized reaction.  The 
acrylyl-CoA is then reduced by the addition of two electrons to form proprionyl-CoA.  
As previously mentioned, proprionyl-CoA donates CoASH via CoA transferase to form 
lactyl-CoA and propionate.  Unlike the components of the succinate-propionate pathway, 
all components of the acrylate pathway have been identified in OhILAs (White, 1995). 
While clostridia are traditionally considered to have a fermentative metabolism, 
anaerobic respiratory processes cannot be negated.  Recently, Imkamp & Mueller (2002) 
have described production of ATP coupled to the reduction of caffeate.  The evidence 
suggests that this reduction occurs via a sodium (Na+) dependent F1/F0 ATPase.  
Genomic of analysis of OhILAs has identified homologs of a Na+ F1/F0 ATPase, NADH 
dehydrogenase and hydrogenase that would provide necessary components for an 
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anaerobic respiratory process (Stolz et al., 2007).  These data, coupled with the previous 
results in which formation acetate was observed without detectable formation of 
propionate, suggest that the reducing equivalents produced from the initial oxidation of 
lactate to acetate may be shuttled to an electron transport system ultimately using 
roxarsone as the terminal electron acceptor to form 3-A-4-HBAA. 
Further supporting this idea are the data obtained with respect to growth rates of 
OhILAs in the presence of roxarsone.  Results of pure culture experiments demonstrated 
a significantly (p < 0.05) higher cell yield in cultures grown in the presence of 1 mM 
roxarsone and either 10 mM lactate or fructose when compared to cultures grown in the 
presence of lactate or fructose alone.  In the case of aerobic respiration, electrons are 
passed from reducing equivalents, generated during glycolysis, such as reduced 
nicotinamide adenine dinucleotide (NADH) along the electron transport chain.  As 
previously discussed, oxygen serves as the terminal electron acceptor in this mode of 
respiration and its reduction to water is ultimately coupled with the generation of copious 
amounts of ATP.  In contrast, subsequent to glycolysis, organisms grown in cultures 
lacking an electron sink must generate ATP from fermentation, a process that produces 
vastly less amounts of ATP (Alberts et al., 2002).   
Since the high energy phosphate bonds serve as the energy currency of the cell, a 
logical argument is made that less ATP yields less growth at a slower rate.  Carried over, 
organisms grown fermentatively would have much slower growth with a much lower cell 
yield than those grown in the presence of a terminal electron acceptor.  Indeed, this is 
what is seen in the cultures grown in the presence of roxarsone and either lactate or 
fructose as the initial carbon source and electron donor.  Using previously obtained data 
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(Fisher, 2006), a standard curve of absorbance versus cells/ml (direct cell count) was 
plotted.  Using the conversion factor (2.98 * 107), generation times during log phase 
growth of the cultures were calculated to be 2.2 hours in cultures grown in the presence 
of roxarsone and lactate while no generation time could be calculated for cultures grown 
in the presence of lactate alone.  Similar results were obtained for cultures grown in the 
presence of roxarsone and fructose, where the generation time is 6.2 hours compared to 
an incalculable generation time for cultures grown on fructose alone.  Moreover, at 60 
hours, the cultures grown in the presence of roxarsone had a nearly ten-fold higher cell 
yield when compared to the cultures lacking roxarsone. 
These results also suggest that a similar process may be occurring in chicken litter 
enrichment cultures.  The pattern of transformant production observed in anaerobic 
experiments using chicken litter enrichments is similar to the patter observed by Stolz 
and colleagues (2007) in pure cultures.  Anaerobic chicken litter enrichment cultures 
rapidly transformed roxarsone to 3-A-4-HBAA initially, followed by release of inorganic 
arsenic species (Stolz et al., 2007).   
Conversely, while aerobic enrichment cultures still showed growth in the presence of 
roxarsone, a presumed antimicrobial, no detectable transformation of roxarsone was 
observed.  These data make to interesting suggestions.  Firstly, despite roxarsone being 
marketed as an antimicrobial, the microbial community of the chicken cecum is well 
suited to growing in the presence of roxarsone.  Secondly, and perhaps more 
interestingly, it further support this them of roxarsone serving as a terminal electron 
acceptor.   
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In the presence of oxygen, lactate would have acted as an electron donor.  The 
electrons generated from metabolic pathways such as the acrylate pathway would have 
been shuttled into an electron transport chain yielding high amounts of ATP but 
ultimately reducing oxygen to water.  Conversely, when grown in the absence of oxygen, 
rapid transformation of roxarsone is seen coupled to increased cell yield. 
The anaerobic culture results are consistent with, and expand on, the work of Cortinas 
and colleagues (2006).  Here, a pure strain of Clostridia was used to monitor the 
transformation whereas Cortinas and colleagues (2006) examined transformation of 
roxarsone in non-specific microbial communities obtained from sewage sludge 
enrichment cultures.  While the composition of the microbial community in the Cortinas 
study remains unresolved, it has been previously established that Clostridia are the 
dominant species of the chicken cecum.  Additionally, these results are consistent with 
results suggesting that roxarsone is degraded during composting and storage of the 
chicken litter under anaerobic conditions (Garbarino et al., 2003). 
Interestingly, these results are not consistent with findings by Brown and colleagues 
(2005) which suggest that aerobic enrichment cultures obtained from soil transform 
roxarsone at a level of 5%.  This difference is possibly attributed to the experimental 
design.  Whereas Brown and colleagues examined aerobic transformation of roxarsone 
using enrichment cultures obtained from soil, the present study is examining the 
transformation of enrichment cultures obtained from chicken litter.  Furthermore, Brown 
and colleagues conducted their experiments at a pH of 5.0 whereas cultures involved in 
the present study are circumneutral at pH 7.3. 
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Physiological roles of 2-nitrophenol transformation 
 Clostridia species are well known for nitroreduction of aromatic compounds.  
Here, the evidence suggests an initial reduction of roxarsone to 3-A-4-HBAA followed 
by further degradation to inorganic arsenic species via pathways as yet uncharacterized.  
Furthermore, the evidence would suggest that roxarsone plays a role in anaerobic 
respiration as a terminal electron acceptor.  To examine the role the arsenic group might 
play in initial reduction of the nitro group, OhILAs cultures were grown in the presence 
of the structurally similar 2-nitrophenol.  The structure of roxarsone consists of an 
aromatic ring with a nitro group located ortho to the 4’ hydroxyl group.  Structurally, this 
is very similar to 2-nitrophenol.  This compound consists of an aromatic ring with a nitro 
group located ortho to a hydroxyl group.  Logically, reduction of the nitro group located 
ortho to the hydroxyl group should occur independently of the presence of an arsenate 
group on the aromatic ring.  Additionally, if reducing equivalents generated during the 
acrylate or similar pathway are shuttled to an electron transport chain with roxarsone 
serving as the terminal electron acceptor, 2-nitrophenol should fulfill this role. 
 Here, anaerobic cultures of OhILAs were grown in the presence of 2-nitrophenol 
alone, or 2-nitrophenol and lactate.  Incomplete transformation of 2-nitrophenol was 
observed as determined by a spectrophotometric assay.  However, this is attributed to 
production of 2-aminophenol.  The full-wavelength profile of the proposed 
transformation product, 2-aminophenol, shows some interference at 410 nm.  
Development of an azo dye based assay should clarify this situation. 
 It is interesting to note, however, that while 2-nitrophenol transformation occurred 
at detectable levels, transformation of 4-nitrophenol did not.  Anaerobic cultures of 4-
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aminophenol grown in the presence or absence of lactate or fructose yielded no increase 
in cell yield over cultures grown in the presence of the carbon source only.  Moreover, no 
detectable level of transformation was observed.  This suggests the substrate specificity 
of the enzymes involved in this pathway, and is consistent with results obtained with 
Trichosporon sp.  Results have suggested that Trichosporon sp. isolated from the Po river 
in Italy are capable of degrading 2-nitrophenol but not 4-nitrophenol.  It is also 
interesting to note that the organisms are capable of degrading 2,4-dinitrophenol, a 
compound not yet tested with OhILAs (Caselli & Hanau, 1994). 
 
OhILAs growth response to addition of 3-A-4-HBAA or 4-hydroxybenzene arsonic acid. 
 As mentioned previously, the primary metabolite of roxarsone transformation by 
OhILAs is 3-A-4-HBAA, however, the remaining mass balance can be accounted for 
with compounds of much greater concern:  arsenate and, to a lesser extent, arsenite (Stolz 
et al., 2007).  While no pathway has been agreed upon, a proposed pathway suggests 
roxarsone is initially reduced to 3-A-4-HBAA and then there is additional degradation of 
this reduced organoarsenical.  For this to occur, growth of OhILAs should still occur in 
the presence of the 3-A-4-HBAA as well as the proposed intermediate, 4-
hydroxybenzene arsonic acid.  Cultures grown in the presence of lactate and of the 
designated organoarsenical showed minimal cell yield over the duration of a 102 hour 
experiment. 
The results of Cortinas and colleagues (2006) suggest that ultimately there is 
complete transformation of 3-A-4-HBAA, though it is a slow process.  Prokaryotes have 
evolved several ways that amino groups can be removed from amino acids.  While 3-A-
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4-HBAA is not an amino acid, the compound may undergo deamination via a similar 
pathway.  Typically, deamination of amino acids occurs by oxidatively deaminating the 
acid to its corresponding keto group.  The keto groups are typically then converted to 
pyruvate and fed into the citric acid cycle (White, 1995).   
Additionally, certain deamination pathways produce additional reducing 
equivalents.  One such pathway is deamination via NAD(P)+-linked dehydrogenases.  
These enzymes reversibly aminate the keto acid and ultimately result in the production of 
ammonium and NADH (White, 1995).  It may be possible that a non-specific NAD(P)+-
linked dehydrogenase is involved in deamination of 3-A-4-HBAA.  If occurring, the 
reducing equivalents produced may be involved in release of arsenic from the aromatic 
ring.  At present, production of the proposed 3-A-4-HBAA transformant 4-
hydroxybenzene arsonic acid has not been detected under laboratory conditions.   
However, strict adherence to the above pathway would result in incomplete 
transformation of 3-A-4-HBAA.  Two electrons would be necessary to reduce the 
arsenate group attached to the aromatic ring to an arsenite group and release it from the 
aromatic ring.  Deamination by this pathway alone produces one reducing equivalent per 
amino group removed, suggesting that two molecules of 3-A-4-HBAA would be required 
for the release of one molecule of arsenite.  Furthermore, it is proposed that inorganic 
arsenic is released in the form of arsenate and is then subsequently reduced to arsenite via 
respiratory mechanisms.  Nonetheless, an adaptation of the above mentioned deamination 
mechanism may hold promise in understanding the release of inorganic arsenic species 
over time without observing production of 4-hydroxybenzene arsonic acid.  Further 
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analysis of the OhILAs genome should prove fruitful in understanding this critical step in 
the degradation pathway. 
To be certain, this is not the only such pathway that is possible.  Pseudomonas sp. 
strain AP-3 utilizes a modified meta-cleavage pathway to metabolize aminophenols 
(Figure 21A) whereby the hydroxyl group located ortho to the amine is oxidized to form 
2-aminomuconic acid via 2-aminomuconic 6-semialdehyde.  Release of carbon dioxide to 
form 2-oxopent-4-enoic acid and addition of water ultimately forms 4-hydroxy-2-
oxovaleric acid.  A modified pathway is suggested in the transformation of 4-amino-3-
hydroxybenzoic acid by Bordetella sp. strain 10d (Figure 21B) whereby 4-amino-3-
hydroxybenzoic acid is ultimately converted to pyruvate and acetaldehyde via 2-amino-5-
carboxymuconic 6-semialdehyde, 2-hydroxy-5-carboxymuconic 6-semialdehyde, 2-
hydroxymuconic 6-semialdehyde, 2-hydroxymuconic acid, 4-oxalocrotonic acid, 2-
oxopent-4-enoic acid and 4-hydroxy-2-oxovaleric acid (Orii et al., 2006).  However, the 
annotated genome does not indicate any of the necessary components for either of these 
transformation pathways. 
 
The OhILAs genome 
 As previously discussed, there are a wide array of arsenate resistance operons.  
The best studied is the operon on plasmid R773, which contains in order arsR, arsD, 
arsA, arsB and arsC, all under the control of a single operator/promoter region.  While 
the minimum requirement for a functioning arsenate resistance system is arsC, all known 
operons contain at least three of these genes.  However, it has been well documented that  
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Figure 21:  Aminophenol metabolism in Pseudomonas and Bordetella sp.  Modified meta-cleavage of 2-
aminophenol by Pseudomonas sp. strain AP-3 (A).  The hydroxyl group located ortho to the 2-
aminophenol (I) amine is oxidized to form 2-aminomuconic acid (III) via 2-aminomuconic 6-semialdehyde 
(II).  Deamination to form 4-oxalocrotonic acid (IV) followed by release of carbon dioxide to form 2-
oxopent-4-enoic (V) acid and addition of water ultimately forms 4-hydroxy-2-oxovaleric acid (V).  
Proposed metabolic pathway (B) of 4-amino-3-hydroxybenzoic acid (I) suggests that the compound is 
ultimately transformed to pyruvate (IX) and acetaldehyde (X) via 2-amino-5-carboxymuconic 6-
semialdehyde (II), 2-hydroxy-5-carboxymuconic 6-semialdehyde (III), 2-hydroxymuconic 6-semialdehyde 
(IV), 2-hydroxymuconic acid (V), 4-oxalocrotonic acid (VI), 2-oxopent-4-enoic acid (VII) and 4-hydroxy-
2-oxovaleric acid (VIII) (Orii et al., 2006). 
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the five gene operon (arsRDABC) encodes a much more effective arsenate resistance 
mechanism than three gene operons, typically arsRBC (Silver et al., 2002).  The 
annotated genome reveals that OhILAs contains an intact five gene arsenate resistance 
operon. 
 Much more poorly understood is the mechanism behind arsenate reduction 
coupled to respiration.  Intriguingly, OhILAs has a respiratory arsenate reductase (arr) 
consisting of arrB, arrA, arrC and arsM.  This is a surprising result since both 
mechanisms transform arsenate to arsenite; however, previous evidence has shown that 
OhILAs is capable of growing in the presence of 40 mM arsenate, but only 10 mM 
arsenite (Fisher, 2006).  Further investigations into the physiology of OhILAs in the 
presence of arsenate and arsenite, as well as a better understood characterization of the 
arr mechanism will aid in understanding these interesting results. 
 Previous research has indicated that arrA can be a reliable marker for 
environmental arsenate respiration.  Between several phylogenetically diverse organisms, 
there was 61-100% conservation at the amino acid (Malasarn et al., 2004).  Though 
OhILAs arrA does not share such high homology with other arsenate reductases, it does 
have 53% identity with Chrysiogenes arsenatis respiratory arsenate reductase (appendix 
1) (Schaeffer et al., 2001)(Altschul et al., 1997).  This enzyme has previously been 
purified and characterized (Krafft & Macy, 1998). 
 C. arsenatis respiratory reductase is a heterodimer consisting of an 87 kDa 
subunit (ArrA) and a 29 kDa subunit (ArrB) with a native molecular determined at 123 
kDa that is localized in the periplasm.  Several possible cofactors were identified for this 
enzyme.  Among these, it is suggested that the enzyme may contain several iron sulfur 
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cluster prosthetic groups as well as a molybdenum cofactor.  Zinc may also be a possible 
cofactor.  The enzyme reduces arsenate to arsentite at neutral pH according to the 
following stochiometry: 
2 HAsO42- + 2 H2AsO4- + 5 H+ + CH3COO- Æ 4 H3AsO3 + 2 HCO3- 
The arsenate reductase of C. arsenatis acts as the terminal reductase in anaerobic 
respiration.  This suggests that, though the enzyme is freely soluble in the periplasm, in 
vivo it remains linked to a membrane bound electron transport chain (Krafft & Macy, 
1998).  
 Topological analysis of these enzymes sequences suggest that they may contain 
transmembrane regions that would anchor the protein to the membrane.  C. arsenatis 
ArrA is predicted to have five inside to outside transmembrane helices and eight outside 
to inside helices (Figure 22).  The ArrA enzyme is predicted to have three inside to 
outside transmembrane helices and four outside to inside transmembrane helices 
(Hofmann &  Stoffel, 1993).  This suggests both enzymes may be capable of anchoring 
themselves to the periplasmic membrane.  More intriguingly, the annotated genome 
suggests that the OhILAs arr operon encodes arrC, a 22.5 kDa anchoring protein. 
 These results could contribute to the inconsistent results obtained here with 
cytosolic and membrane fractions of OhILAs.  In vitro, as well as in gel activity assays 
suggested that arsenate reductase activity was constitutive across the samples.  However, 
no localization pattern was able to be determined from the results since all fractions 
tested positive for arsenate reductase activity.  One possible explanation for this is that 
under non-denaturing conditions, a certain percentage of the ArrA subunit would have 
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Figure 22:  Topological prediction of ArrA from Chrysiogenes arsenatis (A) and OhILAs (B).  
Topological prediction performed using TMpred. http://www.ch.embnet.org/software/TMPRED_form.html 
A 
B 
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 remained attached to ArrC, and consequently activity would have been observed in the 
membrane fractions.  Addition of the reductant dithiothreitol, however, would have 
caused a certain percentage of the enzyme to release from the membrane bound anchor 
and would have produced activity in the soluble fraction. 
 Another possibility exists, however.  While this assay suggests that expression of 
an arsenate reduction enzyme may be constitutively expressed, it must be noted that both 
oxidizers (arsenate) and reducers (methyl viologen) were present in very high 
concentrations.  In conditions such as these, it is not an unreasonable situation where a 
reductase, acting as a promiscuous enzyme, would non-specifically transfer electrons 
from methyl viologen to arsenate resulting in a subsequent clearing of the gel or would 
alter the levels of specific activity observed in vitro. 
 These results conflict with earlier results of arrA expression patterns in C. 
arsenatis.  C. arsenatis grown in the presence of arsenate and nitrate had an almost 
identical specific activity compared to cultures grown in arsenate alone.  However, 
cultures grown in the absence of arsenate but the presence of nitrate, the specific activity 
was only 4% of the maximum (Krafft & Macy, 1998).  Here, lower arsenate reductase 
activity is observed in cultures grown in the presence of arsenate.  It should be noted, 
however, that C. arsenatis cultures began to produce more arsenate reductase with two 
thirds of the original specific activity after a certain time point (Krafft & Macy, 1998).  
This could provide insight into the lower specific activities seen here in the arsenate 
cultures.   
For consistency between cultures, harvesting was performed at 72 hours, despite 
an increased growth rate in arsenate containing cultures when compared to cultures 
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grown in the presence of lactate alone, or lactate and either roxarsone or 2-nitrophenol.  
Unfortunately Krafft and Macy (1998) do not report at what phase of growth this change 
in specific activity occurred.  If this change occurred at plateau phase, which may be 
suggested by their findings, then a similar change may have occurred in OhILAs cultures 
reaching plateau phase.  This may contribute to the decreased specific activity observed 
here. 
 To reach a better understanding of arrA expression patterns in OhILAs, fractions 
grown in the presence of lactate alone, or lactate and either roxarsone, 2-nitrophenol or 
sodium arsenate were Western blotted using rabbit raised Anti-ArrA1 rabbit antibody 
which was affinity purified.  Anti-ArrA1 was raised to a purified peptide strand from the 
Bacillus selenitereduscens ArrA.  While there is similarity, there is only 50% identity 
between OhILAs ArrA and that of B. selenitereduscens.  Low similarity, and 
consequently low affinity, could contribute to poor development after extended 
development times. 
 
In vitro assay of roxarsone transformation 
 Release of OhILAs’ draft annotated genome has suggested many novel enzyme 
targets that could be of interest to understanding the mechanism of roxarsone 
transformation.  Among these proteins of interest, OhILAs contains a coding region 
specifying for a sodium dependent F1/F0 ATP synthase.  Previous evidence has 
demonstrated that reduction of another nitroaromatic, caffeate,  by Acetobacter woodii 
was sodium dependent (Imkamp & Müller, 2002).   
 The present study begins development of an in vitro assay aimed at detecting 
production of the proposed aminophenol products from transformation of roxarsone or 3-
93 
A-4-HBAA.  Here, a diazonium salt is formed between NEDD and the aminophenolic 
compound at low pH.  Production of the amino compound can then be measured 
spectrophotometrically.  Development and refinement of this technique is crucial to 
further understand the mechanism by which roxarsone is ultimately transformed into the 
inorganic arsenic species observed in both cultures of OhILAs as well as enrichment 
cultures obtained from chicken litter. 
 
Conclusions 
 This present study has examined the microbial transformation of roxarsone using 
both a microbial physiology and proteomic approach.  As previously seen, anaerobic 
enrichment cultures obtained from chicken litter exhibit a clostridial style transformation 
of roxarsone; however, cultures grown aerobically do not.  Physiological studies have 
indicated that pure cultures of OhILAs transforming this and similar compounds 
containing a nitro group yield significantly higher cell yields compared to cultures grown 
in their absence.  Taken together, these data suggest a respiratory mode of transformation. 
 Several key enzymes have been identified in the annotated genome of OhILAs.  
Among these are components of both the respiratory arsenate reductase mechanism (arr) 
and the resistance arsenate reductase mechanism (ars), as well as components of an 
anaerobic respiratory chain such as a sodium dependent F1/F0 ATP synthase.  Despite 
evidence suggesting that cultures grown under varying conditions are able to reduce 
arsenate to arsenite, the expression pattern of ArrA1 remains unclear, as does its pattern 
of localization within the cell. 
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Future directions 
 This study lays crucial groundwork for the development of a working model of 
roxarsone transformation.  The data presented here strongly support a theme where 
respiratory processes are coupled to initial transformation of the nitro group; however, 
there is still much work to be done to solidify these results.  Firstly, while there is 
mounting evidence to suggest this is a respiratory process, the results are not yet 
conclusive.   
 It will be interesting to understand what additional compounds OhILAs is capable 
of transforming in a respiration-like pattern.  Chemically, arsenate is analogous to 
phosphate, and behaves much the same way in biological systems.  A radioactively 
labeled phosphorous analog will allow much more detailed study of the mechanism 
behind the transformation.  Additionally, cultures grown in the presence of thiosulfate or 
perhaps nitrate will allow a much better understanding of the free energy requirements of 
the system. 
Growth experiments conducted in the presence of roxarsone with OhILAs strains 
that have had components of the proposed respiratory chain deleted will be very 
informative.  Further genetic techniques can also be employed to better understand the 
results of in vitro assays.  It will be interesting to examine the physiology of 
nitroreductase negative strains of OhILAs grown in the presence of arsenate alone and 
arsenate and nitrate.  In vitro nitrate reduction assays, similar to the arsenate reduction 
assays performed here, can be performed to determine the specific activity of arsenate 
reductase grown in the presence of nitrate.  Additionally, in vitro assays performed on 
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OhILAs∆arr strains will be informative about the possibility of promiscuous enzymes 
contributing to erroneous results. 
Additionally, as mentioned, initial success with in vitro assays to monitor 
disappearance of roxarsone with protein suspensions is crucial.  Refinement of this 
technique, as well as the technique to detect concentrations of the amino-organics will be 
necessary.  This will allow not only data to be presented on the disappearance of the 
initial compound, but concentrations of the final product will be quantifiable. 
 Beyond this, comparative studies investigating the proteomic response of OhILAs 
will be necessary.  The annotated genome has revealed several coding regions of interest.  
Already, certain protein bands of interest have been identified from single dimension 
SDS-PAGE gels (Figure 23) and are undergoing MS/MS analysis by Peter Chovanec.  
Two dimensional gel electrophoresis of samples grown under the different conditions 
will reveal further exciting and unexpected differences between the proteomes, 
confirming involvement of certain enzymes, and perhaps demonstrating involvement of 
novel enzymes in the pathway. 
 There has been limited success with this technique, though the results are far from 
reliable.  Unfortunately, the annotated genome suggests that the proteins of present 
interest have a high likelihood of being either integral membrane proteins or membrane 
associated proteins.  Two-dimensional gel electrophoresis will be a powerful technique to 
employ, however, the difficulties associated with 2D-PAGE of membrane proteins must 
be overcome.  CHAPS solubilization of fractions may provide initial success towards 
development of this technique for these purposes. 
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Figure 23:  Single dimension SDS-PAGE of OhILAs cytosolic and membrane fraction grown in the 
presence of lactate alone (L) or lactate and either roxarsone (R) or arsenate (As).  Bands indicated are 
undergoing MS/MS analysis.by Peter Chovanec. 
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 Additionally either native purification, or purification of overexpressed enzymes 
in another organism, will provide additional avenues to pursue.  Currently, western blot 
analysis is difficult because of the low homology between Bacillus selinitereduscens 
ArrA1 and that of other organisms.  Purification of the OhILAs ArrA1 will allow primary 
antibodies with better specificity and affinity allowing better analysis of expression 
patterns under a variety of conditions.  Purification of these enzymes will also allow more 
detailed analysis of enzyme activity as determined by in vitro assays. 
 Of primary interest, however, is development of a workable model for 
transformation of roxarsone.  Results of Cortinas and colleagues (2006) have 
demonstrated complete transformation of the proposed metabolites from 3-nitro 
transformation from sewage sludge.  Unfortunately, as detailed at length, this data is from 
a complex microbial community, the composition of which has yet to be determined.  
Ultimately, the key to understanding metabolism of 3-A-4-HBAA and subsequent 
intermediates in the process may lie in better understanding the mechanism of 
transformation from roxarsone to 3-A-4-HBAA.  To date, evidence documenting the role 
environmental changes, such as changes in pH coupled to transformation of roxarsone, 
may have on this mechanism possibly leave an insurmountable void until this process is 
understood.  Ultimately, a solid characterization of the mechanism and enzymes involved 
in this pathway is crucial, and should provide for exciting research in the ensuing years. 
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Appendix 1 
 
Vitamin Mix: 
 
1. Biotin – 2 mg/L 
2. Folic Acid – 2 mg/L 
3. Pyridoxine HCl – 10 mg/L  
4. Riboflavin – 5 mg/L 
5. Thiamin – 5 mg/L 
6. Nicotinic Acid – 5 mg/L 
7. Pantothenic Acid – 5 mg/L 
8. p-Aminobenzoic Acid – 5 mg/L 
9. Thioctic Acid – 5 mg/L 
10. B12 – 0.1 mg/L 
 
Filter sterilize.  Store at 4oC in light protective bottle. 
 
 
 
 
 
 
Mineral Mix: 
 
1. Nitrilotriacetic acid – 1.5 g/L 
2. Magnesium sulfate – 3.0 g/L 
3. Manganous chloride – 0.444 g/L 
4. Sodium chloride – 1.0 g/L 
5. Ferric chloride – 0.067 g/L 
6. Calcium chloride; dihydrate – 0.1 g/L 
7. Cobalt chloride – 0.1 g/L 
8. Zinc sulfate 7-hydrate – 0.274 g/L 
9. Cupric sulfate 5-hydrate – 0.01 g/L 
10. Aluminum potassium sulfate – 0.01 g/L 
11. Boric acid; granular – 0.01 g/L 
12. Sodium molybdate – 0.025 g/L 
13. Nickelous chloride 6-hydrate – 0.024 g/L 
14. Sodium tungstate; hydrate – 0.025 g/L 
 
Filter sterilize.  Store at 4oC in light protective bottle. 
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Phosphate Buffered Solution: 
 
1. Sodium chloride – 8 g/L 
2. Sodium phosphate (dibasic) – 0.2 g/L 
3. Potassium phosphate (monobasic) – 1.15 g/L 
4. Calcium chloride CaCl2·2H2O – 0.1 g/L 
5. Magnesium chloride MgCl·6H2O – 0.15 g/L 
 
Store at 4oC 
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Results of Protein BLAST w/ ArrA Chrysiogenes arsenatis 
 
Query  78   EGEWKPSGCLGCTSWCAKQVYIVDGRAIKIKANDESKIHGGNDCPRAHLAVQQVYDADRI  137 
            EG+W PS C GCT+WC  +         K  A   SK + G  C R HL +QQ+YD DRI 
Sbjct  42   EGKWIPSTCQGCTTWCPVEFLFRMAVRSKYAATQLSKANNGYCCVRGHLMLQQLYDPDRI  101 
 
Query  138  KQPMKRTNPKKGRDEDPMFVPISWD-EAMDTLADKIMELRTNNETHKFMLLRGRYTNITD  196 
            K PMKRTNP KGR EDP   P     +  DT+ADKIMELR NNETHK++L+RGRY++    
Sbjct  102  KTPMKRTNPVKGRKEDPKICPYHMGMKQWDTIADKIMELRKNNETHKYLLMRGRYSDHNS  161 
 
Query  197  LFYSSMPKIIGSPNNISHSSICAEAEKFGPYYTQGYWNYRDYDVQNTKYMICWGVDPLCS  256 
            +FY  + K+IGSPNNISHS+ICAE EK G   T+G+W YRDYD+ N KY+I W  DPL S 
Sbjct  162  IFYGDLTKMIGSPNNISHSAICAEVEKMGSMATEGFWGYRDYDLDNMKYLIAWACDPLSS  221 
 
Query  257  NRQVSHYLNVFGELLKKGVKIVTIDPKYSSTAAKSHVWMPVIPGQDGALATAMAHVILAE  316 
            NRQ+ + +     ++ +G K+V +DP+ ++TA+K+  W+P+ P +DGALA AMAHVI+ + 
Sbjct  222  NRQIPNAIRKIQGVMDRG-KVVAVDPRMNNTASKAQEWLPIKPSEDGALALAMAHVIITK  280 
 
Query  317  GLWSREFVGDFTDGNNAFISGKNVKEETFEEIHTHGVVKWWNLELKDRTPEWAEAICGVD  376 
            GLWS+EFVGDF DG N F++GK VKEE FEE  T+G+VKWWNLE+KDRTP+WA  + G+D 
Sbjct  281  GLWSKEFVGDFKDGKNKFVAGKTVKEEDFEEKLTNGIVKWWNLEVKDRTPKWAAKVTGID  340 
 
Query  377  AATIRNVAIEFAKAAPYSMVFMGGGSNMQVRGAYNSMAVHALNGLVGCIDHEGGVLTGRS  436 
             ATI  VA EFA+AAP   ++ G   NMQ RG+Y  M +HALNGLVG  D EGG+ TG   
Sbjct  341  EATIIRVATEFAQAAPACAIWYG--PNMQPRGSYAVMCIHALNGLVGASDSEGGLCTGMG  398 
 
Query  437  AKLNSLPGPDDFMDEMAKTNSKNKKMDQRGTKQFPALKEGKPGSGVITNRVADAILAEDP  496 
            +  +S P  D + D++AK  +KNKK+DQRGT +FPA+   KPG+GV+TN VADA+LA DP 
Sbjct  399  SPSSSYPKIDAYQDDVAKAGAKNKKIDQRGTLKFPAMGSAKPGTGVVTNNVADALLAADP  458 
 
Query  497  YLPKVVIGYFCNFNYSCPGTDRWDKAMSKIEFFAHCVTHYSEMSHFADLLLPSTHHMFEQ  556 
            Y  KV IGYFCNFN+S     RWDKA++K+ FF HCV  +SEM++FAD++LP+  H  E  
Sbjct  459  YDIKVAIGYFCNFNFSGTDGARWDKALAKVPFFVHCVPMFSEMTYFADIVLPAALHHTED  518 
 
Query  557  MASAAQKANSYTHLWITQRLIEPVYDVKNPESEVLWMLAEKLEQRGFSNLLDFC-KTVKD  615 
             A    KAN + H  I Q ++E ++DVK  E+E+ W+LAEKL+ +GF N+ ++     KD 
Sbjct  519  WAVIRSKANLHGHTSIQQPVVERMFDVKGVETEITWLLAEKLKAKGFENMYNWLYNEYKD  578 
 
Query  616  PETGSEPTNGLEFELYAYKTLTQSIWDPTKYTELENHGDKFNSWNEFIQKGVWNSDPYKF  675 
            PETG  PTN LEF LYA K  ++  WDP +  E +  GDK N W +F++KG+ NS  +KF 
Sbjct  579  PETGKNPTNSLEFALYATKIRSKKCWDPKENAEYK--GDKLNGWADFMEKGIVNSPKFKF  636 
 
Query  676  KGLWSK-MKTETTKFEFYSETLKKALQEHADKHNTDVDDILATCKYTGKGEQAFIPHYEP  734 
            +  W K   TET KFEFYSETLKK L  HA+K+   VD ++    Y  +GE AFIPHYE  
Sbjct  637  RQKWEKGFPTETKKFEFYSETLKKGLLAHAEKNKVTVDQVMEATNYEARGELAFIPHYES  696 
 
Query  735  PYMEGKVEQYPFAYIDSKSRLAREGRSANCSWFQEFKDADPGDIKWSDCIKMNPKDAIEL  794 
            P   G V+++PF+ ID KSRL REGRS N +W+  FK  DPGD+   D +++NP DA +L 
Sbjct  697  PKRHGDVKEFPFSLIDMKSRLNREGRSTNATWYHAFKKCDPGDVNQEDVLQINPADAKKL  756 
 
Query  795  GLKDGDKVKVTSPTGEIVTTLKLWEGLRPGTVQKNYGQGHWAMGHVAAEDFEKKLSRGGN  854 
            G+ +GD VKVTS  G +    +LWEG+RPG V K YGQGH+AMG V+A+DF K ++RG N 
Sbjct  757  GINEGDMVKVTSVIGSLTVKARLWEGVRPGCVAKCYGQGHFAMGRVSAKDFGKAVARGAN  816 
 
Query  855  SNVIIPADYERLSGATAYYGSFR-VKIERA  883 
             N I+PADY+R++GATA  G F  VKIE+A 
Sbjct  817  FNDIMPADYDRITGATARNGGFTGVKIEKA  846 
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